Neurofeedback Research Overview (V2)

Overview of Neurofeedback Research
This document contains summaries of the current research related to EEG neurofeedback as
applied in seven major areas of brain health: attention-deficit hyperactivity disorder (ADHD),
addictive disorders, anxiety, cognitive decline, depression, peak performance, and
post-traumatic stress disorder (PTSD). This is followed by lists of academic references for
studies reporting on neurofeedback research in a wide range of brain health applications, as
well as references on conceptual and methodological considerations, and a list of references
that include guidelines for clinicians and researchers. Each reference list is subdivided into
studies, case reports, and reviews.
Research Summaries
Attention-Deficit Hyperactivity Disorder (ADHD)
ADHD is the most well-studied condition in neurofeedback research. Based on
meta-analyses and large multicenter randomized controlled trials (RCTs), two frequency
neurofeedback protocols researched for more than 40 years have been shown efficacious and
specific for ADHD: theta-beta ratio (TBR) and sensorimotor rhythm (SMR) (AAPB Guidelines; La
Vaque et al., 2002). Frequency neurofeedback for ADHD received a grade 1 (‘‘best support’’)
rating from the American Academy of Pediatrics in 2013.
TBR aims to decrease theta (4–7 Hz) and/or increase beta (12–21 Hz) power in central
and frontal locations to reduce the high theta-beta ratios, high theta power, and/or low beta
power characteristic of children and adults with ADHD. Recent RCTs suggest that 30–40
sessions of TBR neurofeedback were as effective as methylphenidate in ameliorating inattentive
and hyperactivity symptoms and were even associated with superior post-treatment academic
performance (Duric et al., 2012; Meisel et al., 2013). SMR over the sensorimotor strip
(predominantly right-central) is based on the functional association of the sensorimotor rhythm
with behavioral inhibition in ADHD. In seminal studies (Lubar & Shouse, 1976; Shouse & Lubar,
1979), it was demonstrated that the beneficial hyperactivity-reducing effects of combined
SMR/theta training were maintained even after psychostimulants were withdrawn in hyperactive
children. Studies suggest that TBR and SMR reduce inattentive and hyperactive/impulsive
symptoms to a similar extent and after a comparable number of training sessions.
A series of meta-analyses have shown that the standard TBR and SMR protocols
improve ADHD symptoms, especially inattention (Arns et al., 2009; Micolaud-Franchi et al.,
2014; Bussalb et al., 2019; Riesco-Matías et al., 2019). Efficacy is clear for parentally-rated
1

symptoms and less certain for teacher-rated symptoms (Micolaud-Franchi et al., 2014; Cortese
et al., 2016; Razoki, 2018; Bussalb et al. 2019). However, parent ratings are associated with
candidate gene pathways (Bralten et al., 2013), and teachers may be less sensitive to change
(Cortese et al., 2016; Bussalb et al., 2019). Using objective cognitive outcomes, a recent
meta-analysis found neurofeedback to be more efficacious than cognitive training in
ameliorating symptoms of inhibition (Lambez et al., 2020). Critically, a meta-analysis focusing
on long-term maintenance found that after an average 6 months from completion of
neurofeedback, the beneficial effects of neurofeedback were superior to semi-active control
groups and methylphenidate (Van Doren et al., 2019). These findings demonstrate that whereas
medication efficacy diminishes over time, neurofeedback efficacy increases. The best evidence
for efficacy comes from double-blind placebo-controlled RCTs, though it is challenging to devise
a placebo condition that properly controls for psychosocial factors like perceptibility and
motivation (Gaume et al., 2016). One of the largest and most comprehensive such trials is
currently being carried out (International Collaborative ADHD Neurofeedback; ICAN; Arnold et
al., 2013; 2018; 2019), with conclusive results anticipated soon.
→
GO TO REFERENCES
Addictive Disorders
EEG neurofeedback has been applied to addictive disorders for over 30 years,
demonstrating promising results in well-controlled intervention studies, good adherence,
reduced addiction severity, and psychosocial benefits even in patients with severe substance
abuse. Consequently, EEG neurofeedback has been classified as “probably efficacious” as an
adjunctive treatment for substance abuse (AAPB Guidelines; La Vaque et al., 2002; Sokhadze
et al., 2008).
Known as the Peniston protocol (or alpha-theta training), the classical neurofeedback
protocol for addictive disorders was originally applied in the treatment of alcoholism (Peniston &
Kulkosky, 1989; Peniston & Kulkosky, 1990). The Peniston protocol assesses EEG activity in an
eyes-closed resting condition while clients aim to increase parietal alpha (8-12 Hz) and theta
(4-7 Hz) associated with a relaxed state, reducing EEG hyperarousal and augmenting coping
skills (Gruzelier, 2009). Due to commonalities between substance use and ADHD, the Peniston
protocol was later supplemented with initial sessions that aim to enhance central sensorimotor
rhythm (SMR; 12-15 Hz) as is done for ADHD. Called the Scott-Kaiser modification, this
composite protocol has been efficacious in individuals with polydrug abuse and high levels of
impulsivity (Scott et al., 1998; Scott et al., 2005); other ADHD-based protocols (e.g., enhance
SMR, inhibit theta and high-beta; Fielenbach et al., 2019) have also been applied. Given
variation in type, duration, and severity of substance use, a neurofeedback protocol
personalized for the observed brain activity has been advocated (Sokhadze et al., 2008).
2

A recent review (Schmidt et al., 2017) identified 7 EEG neurofeedback clinical
intervention trials in substance use since 2010, including 4 randomized controlled trials (RCTs).
Disorders included misuse of: opiates (2 studies; Dehghani-Arani et al., 2010; Dehghani-Arani
et al., 2013), stimulants like cocaine and methamphetamine (3 studies; Hashemian et al., 2015;
Horrell et al., 2010; Rostami & Dehghani-Arani, 2015), alcohol (1 study; Lackner et al., 2015),
and mixed substance and polydrugs (1 study; Keith et al., 2015). Sample sizes ranged from
10-100, and the number of neurofeedback sessions varied from 10-30. Neurofeedback
protocols were mainly the Peniston protocol (some with adjustments; see also Dalkner et al.,
2017) and Scott-Kaiser modification. In all studies, neurofeedback supplemented other
interventions (e.g., pharmacotherapy, psychosocial like cognitive behavioral therapy [CBT]).
Except for the alcohol dependence study, all studies reported positive addiction-related
outcomes, especially reductions of addiction severity and craving. There were also global
psychological and health improvements in most studies. Two studies reported objective
measures, showing substance use abstinence in a urine test (Horrell et al., 2010) and improved
scores on neuropsychological tests of attention and impulsivity (Keith et al., 2015). Changes in
baseline alpha and theta activity were found in alcohol dependence, as well as changes in the
overall EEG, SMR and (reduced) gamma in opiate dependence. The one sham-controlled study
revealed superiority of alpha-theta neurofeedback in clients with methamphetamine misuse
compared with sham (Hashemian, 2015). Critically, one study showed the superiority of
neurofeedback to psychotherapy, with equivalent efficacy for clinician- and computer-guided
neurofeedback (Keith et al., 2015). In sum, recent studies show promising short-term effects of
EEG neurofeedback in reducing craving and modifying dysfunctional brain activity. Additional
RCTs are needed that aim to control for nonspecific effects by comparison with other
psychophysiological treatments (e.g., electrodermal/HRV biofeedback); RCTs with long-term
follow-up are needed to evaluate the occurrence of relapse.
→
GO TO REFERENCES
Anxiety
Alpha-theta (alpha, theta, alpha-theta enhancement) neurofeedback training, which
reduces arousal, has been applied to reduce anxiety (as well as addiction) and create a
generally relaxed state of well-being (Moore, 2000; Gruzelier, 2009). EEG neurofeedback offers
an attractive option, as medication is only mildly more effective than placebo in treating anxiety
disorders. Training is typically administered with eyes closed while listening to auditory feedback
for a total of 7-12 hours of training.
As applied to generalized anxiety disorder (GAD), 9 of 10 neurofeedback studies
reviewed by Moore (2000) and Hammond (2005a,b) produced positive changes in clinical
outcome, with evidence for an anxiety reduction that endures even after 18 months (Watson et
3

al., 1978). Indeed, for anxiety disorders, neurofeedback qualifies for the evidence-based
designation of an efficacious treatment (Hammond, 2005a,b), with GAD and phobic anxiety
disorder (as well as PTSD, summarized separately), demonstrating effects beyond placebo and
meeting criteria for “probably efficacious” on the basis of American Psychological Association
Clinical Psychology Division (Chambless & Hollon, 1998) and biofeedback specialty criteria (La
Vaque et al., 2002). A recent systematic review of biofeedback in anxiety disorders (Tolin et al.,
2020) reported a large advantage for EEG neurofeedback over wait list control groups, with
higher quality studies showing superior effects; there was no clear benefit relative to active
control groups, though few such studies were available to be included.
In a GAD study of high-talent musicians performing under stressful conditions, only
musicians who received alpha-theta (enhancement) training yielded enhanced musical
performance under stress (Egner & Gruzelier, 2003). In one RCT of test anxiety, neurofeedback
participants generated 33% more alpha and showed a significant reduction in anxiety; by
comparison, untreated participants and those receiving relaxation training experienced no
significant symptom reduction (Garrett & Silver, 1976). A recent study in adolescents with
self-reported attention and anxiety (e.g., thoughts of worry) symptoms found enhanced alpha
and sensorimotor rhythm (SMR) along with improved symptoms (by visual analogue scales)
after neurofeedback training of alpha, theta, and SMR twice a week for five weeks (Tsatali et al.,
2019).
→
GO TO REFERENCES
Cognitive Decline
Neurofeedback has been applied to improve cognitive function in a variety of conditions,
most prominently attention-deficit hyperactivity disorder (ADHD), associated with impaired
attention and executive function (see separate research summary). There is now an emerging
body of research on neurofeedback for improving cognitive function in such conditions as stroke
(Kober et al., 2015; 2017) and multiple sclerosis (Kober et al., 2019; Keune et al., 2019), with a
particular focus on Alzheimer’s disease (AD), the most common form of dementia, as well as
mild cognitive impairment (MCI), a pre-dementia condition (Petersen et al., 2004; Albert et al.,
2011), in the hopes of delaying the insidious cognitive decline and dementia onset.
Memory impairment is the hallmark of early AD and its precursor amnestic MCI (aMCI);
other cognitive domains may also be impaired. In the EEG, MCI and AD are generally
characterized by an increase in slow frequencies (delta: 2-4 Hz; theta: 4-8 Hz) and a decrease
in faster frequencies (alpha: 8-12 Hz; beta: 13-20 Hz) (Vigil & Tataryn, 2017). These EEG
features have been linked to poor cognitive performance (Klimesch, 1999), atrophy of thalamus,
hippocampus and basal ganglia (Moretti et al., 2012; Wolf et al., 2004), and the formation of
amyloid-beta plaques (Sharma & Nadkarni, 2020). Notably, a smaller change in alpha between
4

eyes-open and eyes-closed states has been tied to psychomotor and cognitive slowing, as well
as memory impairment in MCI (Van der Hiele et al., 2007) and AD (Pritchard et al., 1991).
Neurofeedback protocols in healthy and mildly impaired older adults have mainly targeted
enhancing alpha, inhibiting theta, or increasing the alpha-theta ratio at posterior sites (e.g.,
Chapin & Russel-Chapin, 2014). Some have used attention training to enhance sensorimotor
rhythm (SMR; low beta) (SMR) or reduce theta-beta ratio (TBR) at central sites (Jiang et al.,
2017; Jang et al., 2019), given that enhancing attention improves encoding, maintenance and
retrieval of items held in working memory.
Several recent studies have reported better memory performance in MCI following
neurofeedback. Lavy and colleagues (2019) found improved verbal memory after ten 30-minute
sessions in which MCI participants enhanced individual central-parietal upper-alpha;
improvement was maintained at 30-day follow-up. Jirayucharoensak and colleagues (2019)
used alpha- and beta-enhancement neurofeedback (twenty 30-minute sessions) as an add-on
to usual care in healthy or aMCI women and found improved rapid visual processing and spatial
working memory. A small MCI study that enhanced beta over dorsolateral prefrontal cortex
found improved memory, cognitive flexibility, complex attention, reaction time, and executive
function (Jang et al., 2019). In AD, studies using individualized neurofeedback protocols have
reported improved cognitive screener performance (Surmeli et al., 2016) and memory/executive
function as compared with wait list control (Berman & Frederick, 2009).
To summarize, initial evidence suggests that EEG neurofeedback is a promising
methodology for timely, effective intervention for cognitive decline. Large-scale controlled trials
with follow-up are needed to identify/validate the optimal protocols to delay MCI onset and
conversion to dementia, as well as elucidate the relationship between neurofeedback and
particular cognitive functions.
→
GO TO REFERENCES
Depression
Neurofeedback for depression is based on well-established EEG research indicating that
the left frontal area is more associated with positive affect, while the right frontal area is more
involved with negative emotion (see, e.g., Davidson, Philos. Trans. R. Soc. Lond. B, 2004). A
biologic predisposition for depression exists when there is an asymmetry in brain wave activity,
such that there is excessive left frontal alpha (8-12 Hz) reflecting less activation and failure to
suppress the subcortical structures that mediate depression (Walker et al., 2007). Indeed
research has shown that when the left frontal region is “stuck” in an alpha idling rhythm, there is
both reduced positive affect and more withdrawal behavior. Conversely, when there is increased
left frontal beta (15-18 Hz), there is more activation and a greater sense of wellbeing.
5

One neurofeedback protocol for modifying this suboptimal brain state involves modifying
the left-right alpha balance at electrodes F3 and F4 (with a Cz reference). Research supports
the efficacy of this ALAY (“alpha asymmetry”) protocol (Choi et al., 2011; Peeters et al., 2014),
including evidence indicating changes in the asymmetry and depressive symptoms endure 1
and 5 years after the end of treatment (Baehr et al., 2001). In a recent study, major depressive
disorder (MDD) most participants who received 1-hour/week ALAY intervention for 6 weeks
regulated their asymmetry and showed improvement in depressive symptoms, though 43%
were non-responders (Wang et al., 2016). Notably, although pharmacologic intervention yields
remission of depression, it does not affect the frontal alpha asymmetry, suggesting that
individuals who receive such intervention continue to have this biomarker for future depression.
Another neurofeedback protocol directly targets reducing left frontal alpha rather than
modifying the left-right alpha balance (Walker et al., 2007). This protocol involves enhancing
left-frontal beta (typically 15-18 Hz) and inhibiting left-frontal theta or alpha to yield greater
activation, which, in turn, generally triggers improved mood. Studies have shown that enhancing
beta and inhibiting theta or alpha at C3 reduced depressive symptoms in most patients (Walker
et al., 2007). In a recent controlled trial, Liu (2017) applied an enhance beta/inhibit alpha
protocol at F3 in 32 college students with MDD. In addition to regulating brainwaves, the
neurofeedback intervention was protective, significantly reducing recurrence and intensity of
depressive symptoms for 3 weeks post-intervention; in contrast, depressive symptoms
increased in active control participants.
→
GO TO REFERENCES
Peak Performance
EEG neurofeedback for ‘peak’ or ‘optimal’ performance focuses on facilitating brain
performance in healthy individuals to achieve maximal brain functioning. Specifically, peak
performance protocols aim to control level of arousal, attention and motivation, optimizing level
of autonomic control and ability to shift states. A concrete goal of peak performance training is
the completion of a specific function or task with fewer errors and greater efficiency, resulting in
a more positive outcome (Vernon, 2005). Twenty-three controlled studies have reported
neurofeedback learning indices along with beneficial outcomes, including gains in: sustained
attention, orienting and executive attention, the P300b event-related potential, memory, spatial
rotation, reaction time, complex psychomotor skills, implicit procedural memory, recognition
memory, perceptual binding, intelligence, mood and well-being (Gruzelier et al., 2014). Gains
have been achieved by a variety of neurofeedback protocols, including: sensorimotor rhythm
(SMR), beta and gamma, theta, and alpha power. Indeed peak performance surpasses other
neurofeedback domains in that the majority of studies demonstrate evidence of learning.
6

Neurofeedback may optimize cognitive processing and learning by modifying white
matter pathways and gray matter volume resulting in faster conduction velocity in neural
networks. With regard to alpha power training, it has been suggested that engaging in a
well-practiced task is associated with elevated alpha power, reflecting decreased cortical
information processing and a more automatic stage of skill acquisition (Mirifar et al., 2017). In
one study, increased SMR power improved accuracy and speed of surgery skills (Ros et al.,
2009). In another study, inhibition of theta power reduced radar detection errors (Beatty et al.,
1974). Egner and Gruzelier (2004) reported faster reaction time in an attention task following an
inhibit theta/enhance mid-beta protocol, and memory improvement has been reported following
upper-alpha training (Escolano et al., 2011; Zoefel et al., 2011). A recent review found that 12 of
14 full studies reported positive effects in athletes, with 7 of 10 showing positive effects on
performance, 3 of 6 studies reporting improved affective outcomes, and 3 of 3 reporting better
cognitive outcomes (Mirifar et al., 2017). Though the evidence is overwhelmingly encouraging,
sample sizes are small, and little is known about how methodological characteristics (e.g.,
number of training sessions, particular neurofeedback protocol) impact outcomes (Vernon et al.,
2009; Mirifar et al., 2017). Thus larger, controlled studies are needed to address these issues
and provide a clear understanding of the specific effects of neurofeedback on peak
performance.
→
GO TO REFERENCES
Post-Traumatic Stress Disorder (PTSD)
Evidence-based practice guidelines for PTSD recommend trauma-focused cognitive
behavioral therapy (CBT) and eye movement desensitization and reprocessing (EMDR) as
effective treatment modalities. However, the dropout rate for these therapies is high (Bisson et
al., 2013; National Institute of Clinical Excellence (NICE), 2005). Pharmacological treatment
(e.g., selective serotonin reuptake inhibitors; SSRIs) may also be effective, but the evidence is
weaker. Further, treatment with pharmacological and psychotherapy-based therapies may last
several years and are ineffectual for ~40% of patients (Bradley et al., 2005; NICE, 2005; Stein et
al., 2006).
EEG neurofeedback is a non-pharmacologic alternative that meets “probably efficacious”
criteria for PTSD (Hammond, 2005a,b; Reiter et al., 2016) on the basis of American
Psychological Association Clinical Psychology Division (Chambless & Hollon, 1998) and
biofeedback specialty criteria (La Vaque et al., 2002). A recent systematic review and
meta-analysis pooled data across four randomized controlled trials (RCTs) in PTSD (n=123)
and revealed a very large effect size (standard mean difference of -2.30; 95% CI: -4.37 to -0.24)
for improvement in PTSD symptoms that exceeded effect sizes for internet-based cognitive
therapy and meditation-related exercises (Steingrimsson et al., 2020). The studies consistently
7

favored neurofeedback in terms of symptom severity and number of patients achieving
remission. Specifically, PTSD symptoms were reduced by 34-66% in the neurofeedback group,
but ranged from a reduction of 15% to an increase of 13% in the control groups (3 passive, 1
active). The one study with follow-up (van der Kolk et al., 2016) reported 46% symptom
reduction posttreatment and 51% symptom reduction at 1-month follow-up (compared with
reductions of 13% posttreatment and 14% at 1-month follow-up in controls). At 1-month
follow-up, 58% (11/19) of neurofeedback patients achieved remission as compared with 11%
(2/19) of controls. In one study (Noohi et al., 2017), neurofeedback significantly improved
performance on cognitive tests of executive function. In another (Peniston & Kulkosky, 1991), all
neurofeedback patients (14/14) reduced psychotropic medication use as compared with one
patient (1/13) in the control group.
Though the extant evidence is encouraging (see also reviews by Reiter et al. 2016;
Panisch & Hai, 2018), additional controlled studies are desirable for greater confidence and
clarity regarding the efficacy of neurofeedback in PTSD. Indeed small, heterogeneous samples
and different study designs preclude specific recommendations for the optimal neurofeedback
protocol. Enhance alpha/inhibit theta protocols are often used for PTSD (e.g., Pensiston &
Kulkosky, 1991; Noohi et al., 2017), but there is considerable variation in the frequency bands
trained (e.g., Pop-Jordanova & Zorcec, 2004 used SMR enhancement), session duration (e.g.,
Kluetsch et al., 2013: single session; Peniston & Kulkosky, 1991: 30 sessions), inter-session
interval and duration of treatment. Also, only one RCT included an active control group (van der
Kolk et al., 2016; standard treatment), and no studies have incorporated a sham control.
→
GO TO REFERENCES
8

Academic Reference Lists
Attention-Deficit Hyperactivity Disorder (ADHD) 11
STUDIES 11
CASE REPORTS 19
REVIEWS 19
Addictive Disorders 25
STUDIES 25
CASE REPORTS 27
REVIEWS 27
Anxiety 28
STUDIES 28
CASE REPORTS 31
REVIEWS 31
Autism Spectrum Disorders (ASD) 33
STUDIES 33
CASE REPORTS 34
REVIEWS 34
Chronic Fatigue Syndrome and Fibromyalgia 35
STUDIES 35
CASE REPORTS 35
REVIEWS 35
Cognitive Decline 36
STUDIES 36
CASE REPORTS 38
REVIEWS 39
Depression 39
STUDIES 39
CASE REPORTS 40
REVIEWS 41
Eating Disorders 41
STUDIES 41
REVIEWS 42
Epilepsy 43
STUDIES 43
CASE REPORTS 44
REVIEWS 45
Learning & Developmental Disabilities 46
STUDIES 46
CASE REPORTS 47
9

REVIEWS 48
Medical Conditions 48
STUDIES 48
CASE REPORTS 50
REVIEWS 50
Obsessive Compulsive Disorder 51
STUDIES 51
REVIEWS 51
Pain and Headache 52
STUDIES 52
CASE REPORTS 53
REVIEWS 53
Peak Performance 53
STUDIES 53
CASE REPORTS 55
REVIEWS 55
Post Traumatic Stress Disorder (PTSD) 56
STUDIES 56
CASE REPORTS 58
REVIEWS 58
Schizophrenia 59
STUDIES 59
CASE REPORTS 60
REVIEWS 60
Sleep 60
STUDIES 60
CASE REPORTS 61
REVIEWS 61
Traumatic Brain Injury (TBI), Stroke, Coma, & Cerebral Palsy 62
STUDIES 62
CASE REPORTS 64
REVIEWS 65
Conceptual/Theoretical 67
STUDIES 67
REVIEWS 68
Methodology & Mechanisms 71
STUDIES 71
REVIEWS 74
Guidelines for Research & Clinical Practice 77
10

Attention-Deficit Hyperactivity Disorder (ADHD)
STUDIES
Arnold, L. E., DeBeus, R., Kerson, C., Monastra, V. J., Rice, R. R., Barterian, J. A., and Pan, X.
(2019). One-year follow-up of double-blind RCT of neurofeedback for ADHD. Journal of
the American Academy of Child & Adolescent Psychiatry 58, S316–S317.
doi:10.1016/j.jaac.2019.07.733.
Arnold, L. E., Kerson, C., Monastra, V., Pan, J., Kraemer, H., Rice, R., Barterian, J. A.,
Schrader, C., and Rhodes, R. (2018). Outcomes of double-blind RCT of neurofeedback
for ADHD. Journal of the American Academy of Child & Adolescent Psychiatry 57, S283.
doi:10.1016/j.jaac.2018.07.666.
Arnold, L. E., Lofthouse, N., Hersch, S., Pan, X., Hurt, E., Bates, B., Kassouf, K., Moone, S.,
and Grantier, C. (2013). EEG neurofeedback for ADHD: Double-blind sham-controlled
randomized pilot feasibility trial. J. Atten. Disord. 17, 410–419.
doi:10.1177/1087054712446173.
Arns, M., Feddema, I., and Kenemans, J. L. (2014). Differential effects of theta/beta and SMR
neurofeedback in ADHD on sleep onset latency. Front. Hum. Neurosci. 8, 1019.
doi:10.3389/fnhum.2014.01019.
Arns, M., Kleinnijenhuis, M., Fallahpour, K., and Breteler, R. (2008). Golf performance
enhancement and real-life neurofeedback training using personalized event-locked EEG
profiles. J. Neurother. 11, 11–18. doi:10.1080/10874200802149656.
Bhayee, S., Tomaszewski, P., Lee, D. H., Moffat, G., Pino, L., Moreno, S., and Farb, N. A. S.
(2016). Attentional and affective consequences of technology supported mindfulness
training: A randomised, active control, efficacy trial. BMC Psychol. 4, 60.
doi:10.1186/s40359-016-0168-6.
Bink, M., Bongers, I. L., Popma, A., Janssen, T. W. P., & van Nieuwenhuizen, C. (2016). 1-year
follow-up of neurofeedback treatment in adolescents with attention-deficit hyperactivity
disorder: Randomised controlled trial. BJPsych Open, 2(2), 107–115.
https://doi.org/10.1192/bjpo.bp.115.000166
Bink, M., van Nieuwenhuizen, C., Popma, A., Bongers, I. L., & van Boxtel, G. J. M. (2015).
Behavioral effects of neurofeedback in adolescents with ADHD: A randomized controlled
11

trial. European Child & Adolescent Psychiatry, 24(9), 1035–1048.
https://doi.org/10.1007/s00787-014-0655-3
Bioulac, S., Purper-Ouakil, D., Ros, T., Blasco-Fontecilla, H., Prats, M., Mayaud, L., and
Brandeis, D. (2019). Personalized at-home neurofeedback compared with long-acting
methylphenidate in an European non-inferiority randomized trial in children with ADHD.
BMC Psychiatry 19, 237. doi:10.1186/s12888-019-2218-0.
Bluschke, A., Friedrich, J., Schreiter, M. L., Roessner, V., and Beste, C. (2018). A comparative
study on the neurophysiological mechanisms underlying effects of methylphenidate and
neurofeedback on inhibitory control in attention deficit hyperactivity disorder.
Neuroimage Clin. 20, 1191–1203. doi:10.1016/j.nicl.2018.10.027.
Boyd, W. D., and Campbell, S. E. (1998). EEG biofeedback in the schools: The use of EEG
biofeedback to treat ADHD in a school setting. J. Neurother. 2, 65–71.
doi:10.1300/J184v02n04_05.
Boynton, T. (2001). Applied research using alpha/theta training for enhancing creativity and
well-being. J. Neurother. 5, 5–18. doi:10.1300/J184v05n01_02.
Breteler, R., Pesch, W., Nadorp, M., Best, N., and Tomasoa, X. (2012). Neurofeedback in
residential children and adolescents with mild mental retardation and ADHD behavior. J.
Neurother. 16, 172–182. doi:10.1080/10874208.2012.705742.
Carmody, D. P., Radvanski, D. C., Wadhwani, S., Sabo, M. J., and Vergara, L. (2000). EEG
biofeedback training and attention-deficit/hyperactivity disorder in an elementary school
setting. J. Neurother. 4, 5–27. doi:10.1300/J184v04n03_02.
Cho, B.-H., Kim, S., Shin, D. I., Lee, J. H., Lee, S. M., Kim, I. Y., and Kim, S. I. (2004).
Neurofeedback training with virtual reality for inattention and impulsiveness.
Cyberpsychol. Behav. 7, 519–526. doi:10.1089/cpb.2004.7.519.
Cueli, M., Rodríguez, C., Cabaleiro, P., García, T., and González-Castro, P. (2019). Differential
efficacy of neurofeedback in children with ADHD presentations. J. Clin. Med. 8, 204.
doi:10.3390/jcm8020204.
Deiber, M.-P., Hasler, R., Colin, J., Dayer, A., Aubry, J.-M., Baggio, S., Perroud, N., and Ros, T.
(2019). Linking alpha oscillations, attention and inhibitory control in adult ADHD with
EEG neurofeedback. Neuroimage Clin. 25, 102145. doi:10.1016/j.nicl.2019.102145.
Dobrakowski, P., and Łebecka, G. (2020). Individualized neurofeedback training may help
achieve long-term improvement of working memory in children with ADHD. Clin. EEG
Neurosci. 51, 94–101. doi:10.1177/1550059419879020.
12

Dupuy, F. E., Clarke, A. R., and Barry, R. J. (2013). EEG activity in females with
attention-deficit/hyperactivity disorder. J. Neurother. 17, 49–67.
doi:10.1080/10874208.2013.759024.
Duric, N. S., Assmus, J., Gundersen, D., Duric Golos, A., and Elgen, I. B. (2017). Multimodal
treatment in children and adolescents with attention-deficit/hyperactivity disorder: A
6-month follow-up. Nord. J. Psychiatry 71, 386–394.
doi:10.1080/08039488.2017.1305446.
Duric, N. S., Assmus, J., Gundersen, D., and Elgen, I. B. (2012). Neurofeedback for the
treatment of children and adolescents with ADHD: A randomized and controlled clinical
trial using parental reports. BMC Psychiatry 12, 107. doi:10.1186/1471-244X-12-107.
Egner, T., and Gruzelier, J. H. (2003). Ecological validity of neurofeedback: Modulation of slow
wave EEG enhances musical performance. Neuroreport 14, 1221–1224.
doi:10.1097/01.wnr.0000081875.45938.d1.
Egner, T., and Gruzelier, J. H. (2004). EEG Biofeedback of low beta band components:
Frequency-specific effects on variables of attention and event-related brain potentials.
Clin. Neurophysiol. 115, 131–139. doi:10.1016/S1388-2457(03)00353-5.
Egner, T., and Gruzelier, J. H. (2001). Learned self-regulation of EEG frequency components
affects attention and event-related brain potentials in humans. Neuroreport 12,
4155–4159. doi:10.1097/00001756-200112210-00058.
Escolano, C., Navarro-Gil, M., Garcia-Campayo, J., Congedo, M., and Minguez, J. (2014). The
effects of individual upper alpha neurofeedback in ADHD: An open-label pilot study.
Appl. Psychophysiol. Biofeedback 39, 193–202. doi:10.1007/s10484-014-9257-6.
Fielenbach, S., Donkers, F. C., Spreen, M., and Bogaerts, S. (2018). Effects of a
theta/sensorimotor rhythm neurofeedback training protocol on measures of impulsivity,
drug craving, and substance abuse in forensic psychiatric patients with substance
abuse: Randomized controlled trial. JMIR Ment Health 5, e10845. doi:10.2196/10845.
Foks, M. (2005). Neurofeedback training as an educational intervention in a school setting: How
the regulation of arousal states can lead to improved attention and behaviour in children
with special needs. Educational and Child Psychology 22, 67–77.
Fritson, K. K., Wadkins, T. A., Gerdes, P., and Hof, D. (2008). The impact of neurotherapy on
college students’ cognitive abilities and emotions. J. Neurother. 11, 1–9.
doi:10.1080/10874200802143998.
13

Fuchs, T., Birbaumer, N., Lutzenberger, W., Gruzelier, J. H., and Kaiser, J. (2003).
Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: A
comparison with methylphenidate. Appl. Psychophysiol. Biofeedback 28, 1–12.
Geladé, K., Janssen, T. W. P., Bink, M., van Mourik, R., Maras, A., and Oosterlaan, J. (2016).
Behavioral effects of neurofeedback compared to stimulants and physical activity in
attention-deficit/hyperactivity disorder: A randomized controlled trial. J. Clin. Psychiatry
77, e1270–e1277. doi:10.4088/JCP.15m10149.
Geladé, K., Janssen, T. W. P., Bink, M., Twisk, J. W. R., van Mourik, R., Maras, A., and
Oosterlaan, J. (2018). A 6-month follow-up of an RCT on behavioral and neurocognitive
effects of neurofeedback in children with ADHD. Eur. Child Adolesc. Psychiatry 27,
581–593. doi:10.1007/s00787-017-1072-1.
González-Castro, P., Cueli, M., Rodríguez, C., García, T., and Álvarez, L. (2016). Efficacy of
neurofeedback versus pharmacological support in subjects with ADHD. Appl.
Psychophysiol. Biofeedback 41, 17–25. doi:10.1007/s10484-015-9299-4.
Hansen, L. M., Trudeau, D. L., and Grace, D. L. (1996). Neurotherapy and drug therapy in
combination for adult ADHD, personality disorder, and seizure disorder. J. Neurother. 2,
6–14. doi:10.1300/J184v02n01_02.
Heywood, C., and Beale, I. (2003). EEG biofeedback vs. placebo treatment for
attention-deficit/hyperactivity disorder: A pilot study. J. Atten. Disord. 7, 43–55.
doi:10.1177/108705470300700105.
Janssen, T. W. P., Bink, M., Weeda, W. D., Geladé, K., van Mourik, R., Maras, A., and
Oosterlaan, J. (2017). Learning curves of theta/beta neurofeedback in children with
ADHD. Eur. Child Adolesc. Psychiatry 26, 573–582. doi:10.1007/s00787-016-0920-8.
Kaiser, D. A., and Othmer, S. (2000). Effect of neurofeedback on variables of attention in a large
multi-center trial. J. Neurother. 4, 5–15. doi:10.1300/J184v04n01_02.
Keith, J. R., Rapgay, L., Theodore, D., Schwartz, J. M., and Ross, J. L. (2015). An assessment
of an automated EEG biofeedback system for attention deficits in a substance use
disorders residential treatment setting. Psychol. Addict. Behav. 29, 17–25.
doi:10.1037/adb0000016.
Kerson, C., and Collaborative Neurofeedback Group (2013). A proposed multisite double-blind
randomized clinical trial of neurofeedback for ADHD: Need, rationale, and strategy. J.
Atten. Disord. 17, 420–436. doi:10.1177/1087054713482580.
14

Kropotov, J. D., Grin-Yatsenko, V. A., Ponomarev, V. A., Chutko, L. S., Yakovenko, E. A., and
Nikishena, I. S. (2007). Changes in EEG spectrograms, event-related potentials and
event-related desynchronization induced by relative beta training in ADHD children. J.
Neurother. 11, 3–11. doi:10.1300/J184v11n02_02.
La Marca, J., and O’Connor, R. (2016). Neurofeedback as an intervention to improve reading
achievement in students with attention deficit hyperactivity disorder, inattentive subtype.
NR 3, 55–77. doi:10.15540/nr.3.2.55.
Lee, E.-J., and Jung, C.-H. (2017). Additive effects of neurofeedback on the treatment of ADHD:
A randomized controlled study. Asian J. Psychiatr. 25, 16–21.
doi:10.1016/j.ajp.2016.09.002.
Leins, U., Goth, G., Hinterberger, T., Klinger, C., Rumpf, N., and Strehl, U. (2007).
Neurofeedback for children with ADHD: A comparison of SCP and theta/beta protocols.
Appl. Psychophysiol. Biofeedback 32, 73–88. doi:10.1007/s10484-007-9031-0.
Linden, M., Habib, T., and Radojevic, V. (1996). A controlled study of the effects of EEG
biofeedback on cognition and behavior of children with attention deficit disorder and
learning disabilities. Biofeedback Self Regul. 21, 35–49. doi:10.1007/bf02214148.
Lubar, J. F., Swartwood, M. O., Swartwood, J. N., and O’Donnell, P. H. (1995). Evaluation of the
effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured
by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performance.
Biofeedback Self Regul. 20, 83–99. doi:10.1007/bf01712768.
McReynolds, C., Villalpando, L., and Britt, C. (2018). Using neurofeedback to improve ADHD
symptoms in school-aged children. NR 5, 109–128. doi:10.15540/nr.5.4.109.
Medici, D., Bayarri, P. G., Chilet, R. C., Ibánez, J. M., Suarez-Varela, M. M., and Calvo, D.
(2018). Neurofeedback versus pharmacological intervention in the treatment of
childhood attention deficit/hyperactivity disorder (ADHD): First Spanish clinical
neuropsychological study. AJAP 7, 57–66. doi:10.11648/j.ajap.20180705.11.
Meisel, V., Servera, M., Garcia-Banda, G., Cardo, E., and Moreno, I. (2013). Neurofeedback
and standard pharmacological intervention in ADHD: A randomized controlled trial with
six-month follow-up. Biol. Psychol. 94, 12–21. doi:10.1016/j.biopsycho.2013.04.015.
Moghanloo, M., Aguilar Vafaie, M., Rostami, R., and Farahani, H. (2014). Determination of the
effects of neurofeedback training in the neuropsychological rehabilitation in inattentive
and combined subtypes of attention deficit/hyperactivity disorder. NR 1, 131–150.
doi:10.15540/nr.1.2.131.
15

Mohagheghi, A., Amiri, S., Moghaddasi Bonab, N., Chalabianloo, G., Noorazar, S. G.,
Tabatabaei, S. M., and Farhang, S. (2017). A randomized trial of comparing the efficacy
of two neurofeedback protocols for treatment of clinical and cognitive symptoms of
ADHD: Theta suppression/beta enhancement and theta suppression/alpha
enhancement. Biomed Res. Int. 2017, 3513281. doi:10.1155/2017/3513281.
Monastra, V. J., Monastra, D. M., and George, S. (2002). The effects of stimulant therapy, EEG
biofeedback, and parenting style on the primary symptoms of
attention-deficit/hyperactivity disorder. Appl. Psychophysiol. Biofeedback 27, 231–249.
doi:10.1023/a:1021018700609.
Moreno-García, I., Meneres-Sancho, S., Camacho-Vara de Rey, C., and Servera, M. (2019). A
randomized controlled trial to examine the posttreatment efficacy of neurofeedback,
behavior therapy, and pharmacology on ADHD measures. J. Atten. Disord. 23, 374–383.
doi:10.1177/1087054717693371.
Nooner, K. B., Leaberry, K. D., Keith, J. R., and Ogle, R. L. (2017). Clinic outcome assessment
of a brief course neurofeedback for childhood ADHD symptoms. J. Behav. Health Serv.
Res. 44, 506–514. doi:10.1007/s11414-016-9511-1.
Perreau-Linck, E., Lessard, N., Lévesque, J., and Beauregard, M. (2010). Effects of
neurofeedback training on inhibitory capacities in ADHD children: A single-blind,
randomized, placebo-controlled study. J. Neurother. 14, 229–242.
doi:10.1080/10874208.2010.501514.
Pratt, R. R., Abel, H.-H., and Skidmore, J. (1995). The effects of neurofeedback training with
background music on EEG patterns of ADD and ADHD children. International Journal of
Arts Medicine 4, 24–31.
Rasey, H., Lubar, J. F., McIntyre, A., Zoffuto, A., and Abbott, P. L. (1995). EEG biofeedback for
the enhancement of attentional processing in normal college students. J. Neurother. 1,
15–21. doi:10.1300/J184v01n03_03.
Rossiter, Dr. T. R., and La Vaque, T. J. (1995). A comparison of EEG biofeedback and
psychostimulants in treating attention deficit/hyperactivity disorders. J. Neurother. 1,
48–59. doi:10.1300/J184v01n01_07.
Rossiter, T. (2004). The effectiveness of neurofeedback and stimulant drugs in treating AD/HD:
Part II. Replication. Appl. Psychophysiol. Biofeedback 29, 233–243.
doi:10.1007/s10484-004-0383-4.
16

Rossiter, T. R. (1998). Patient-directed neurofeedback for AD/HD. J. Neurother. 2, 54–64.
doi:10.1300/J184v02n04_04.
Russell-Chapin, L., Kemmerly, T., Liu, W.-C., Zagardo, M. T., Chapin, T., Dailey, D., and Dinh,
D. (2013). The effects of neurofeedback in the default mode network: Pilot study results
of medicated children with ADHD. J. Neurother. 17, 35–42.
doi:10.1080/10874208.2013.759017.
Ryoo, M., and Son, C. (2015). Effects of neurofeedback training on EEG, continuous
performance task (CPT), and ADHD symptoms in ADHD-prone college students. J.
Korean Acad. Nurs. 45, 928–938. doi:10.4040/jkan.2015.45.6.928.
Scheinbaum, S., and Newton, C. J. (1995). A controlled study of EEG biofeedback as a
treatment for attention-deficit disorders. Biofeedback Self Regul 20, 295.
Shereena, E. A., Gupta, R. K., Bennett, C. N., Sagar, K. J. V., and Rajeswaran, J. (2019). EEG
neurofeedback training in children with attention deficit/hyperactivity disorder: A cognitive
and behavioral outcome study. Clin. EEG Neurosci. 50, 242–255.
doi:10.1177/1550059418813034.
Shin, M.-S., Jeon, H., Kim, M., Hwang, T., Oh, S. J., Hwangbo, M., and Kim, K. J. (2016).
Effects of smart-tablet-based neurofeedback training on cognitive function in children
with attention problems. J. Child Neurol. 31, 750–760. doi:10.1177/0883073815620677.
Steiner, N. J., Frenette, E. C., Rene, K. M., Brennan, R. T., and Perrin, E. C. (2014). In-school
neurofeedback training for ADHD: Sustained improvements from a randomized control
trial. Pediatrics 133, 483–492. doi:10.1542/peds.2013-2059.
Sudnawa, K. K., Chirdkiatgumchai, V., Ruangdaraganon, N., Khongkhatithum, C.,
Udomsubpayakul, U., Jirayucharoensak, S., and Israsena, P. (2018). Effectiveness of
neurofeedback versus medication for attention-deficit/hyperactivity disorder. Pediatr. Int.
60, 828–834. doi:10.1111/ped.13641.
Swingle, P. G. (2002). Parameters associated with rapid neurotherapeutic treatment of common
ADD (CADD). J. Neurother. 5, 73–84. doi:10.1300/J184v05n04_05.
Swingle, P. G. (1996). Subthreshold 10-Hz sound suppresses EEG theta: Clinical application for
the potentiation of neurotherapeutic treatment of ADD/ADHD. J. Neurother. 2, 15–22.
doi:10.1300/J184v02n01_03.
Thompson, L., and Thompson, M. (1998). Neurofeedback combined with training in
metacognitive strategies: Effectiveness in students with ADD. Appl. Psychophysiol.
Biofeedback 23, 243–263. doi:10.1023/a:1022213731956.
17

Thompson, M., and Thompson, L. (2006). Improving attention in adults and children: Differing
electroencephalography profiles and implications for training. Biofeedback 34, 99–105.
Tinius, T. P., and Tinius, K. A. (2000). Changes after EEG biofeedback and cognitive retraining
in adults with mild traumatic brain injury and attention deficit hyperactivity disorder. J.
Tsatali, M., Sidiropoulos, S., and Bamidis, P. (2019). Effective neurofeedback applications in
anxiety and attention symptomatology in adolescents. L’Encéphale 45, S80.
doi:10.1016/j.encep.2019.04.041.
Van Doren, J., Heinrich, H., Bezold, M., Reuter, N., Kratz, O., Horndasch, S., Berking, M., Ros,
T., Gevensleben, H., Moll, G. H., et al. (2017). Theta/beta neurofeedback in children with
ADHD: Feasibility of a short-term setting and plasticity effects. Int. J. Psychophysiol. 112,
80–88. doi:10.1016/j.ijpsycho.2016.11.004.
Vernon, D., Egner, T., Cooper, N., Compton, T., Neilands, C., Sheri, A., and Gruzelier, J.
(2003). The effect of training distinct neurofeedback protocols on aspects of cognitive
performance. Int. J. Psychophysiol. 47, 75–85. doi:10.1016/S0167-8760(02)00091-0.
Wang, Z. (2017). Neurofeedback training intervention for enhancing working memory function in
attention deficit and hyperactivity disorder (ADHD) Chinese students. Neuroquantology
15, 277–283. doi:10.14704/nq.2017.15.2.1073.
Warner, D. A., Barabasz, A. F., and Barabasz, M. (2000). The efficacy of Barabasz’s alert
hypnosis and neurotherapy on attentiveness, impulsivity and hyperactivity in children
with ADHD. Child Study Journal 30, 43–49.
Xiong, Z., Shi, S., and Xu, H. (2005). A controlled study of the effectiveness of EEG biofeedback
training on-children with attention deficit hyperactivity disorder. J. Huazhong Univ. Sci.
Technol. Med. Sci. 25, 368–370. doi:10.1007/bf02828171.
Yang, P., Ting Li, I., and Ling Liu, T. (2018). Electroencephalogram neurofeedback treatment for
Taiwanese children with attention deficit hyperactivity disorder. Neuropsychiatry 8,
146–154. doi:10.4172/Neuropsychiatry.1000335.
CASE REPORTS
Alhambra, M. A., Fowler, T. P., and Alhambra, A. A. (1995). EEG biofeedback: A new treatment
option for ADD/ADHD. J. Neurother. 1, 39–43. doi:10.1300/J184v01n02_03.
18

Fleischman, M. J., and Othmer, S. (2006). Case study: Improvements in IQ score and
maintenance of gains following EEG biofeedback with mildly developmentally delayed
twins. J. Neurother. 9, 35–46. doi:10.1300/J184v09n04_03.
Jacobs, E. H. (2006). Neurofeedback treatment of two children with learning, attention, mood,
social, and developmental deficits. J. Neurother. 9, 55–70. doi:10.1300/J184v09n04_06.
Rossiter, T. (2002). Neurofeedback for AD/HD: A ratio feedback case study and tutorial. J.
Tansey, M. A. (1993). Ten-year stability of EEG biofeedback results for a hyperactive boy who
failed fourth grade perceptually impaired class. Biofeedback Self Regul. 18, 33–44.
doi:10.1007/bf00999512.
Tansey, M. A., and Bruner, R. L. (1983). EMG and EEG biofeedback training in the treatment of
a 10-year-old hyperactive boy with a developmental reading disorder. Biofeedback Self
Regul. 8, 25–37. doi:10.1007/bf01000534.
Wadhwani, S., Radvanski, D. C., and Carmody, D. P. (1998). Neurofeedback training in a case
of attention deficit hyperactivity disorder. J. Neurother. 3, 42–49.
doi:10.1300/J184v03n01_05.
REVIEWS
Arns, M. (2012). EEG-based personalized medicine in ADHD: Individual alpha peak frequency
as an endophenotype associated with nonresponse. J. Neurother. 16, 123–141.
doi:10.1080/10874208.2012.677664.
Arns, M., Batail, J. M., Bioulac, S., Congedo, M., Daudet, C., Drapier, D., Fovet, T., Jardri, R.,
Le-Van-Quyen, M., Lotte, F., et al. (2017). Neurofeedback: One of today’s techniques in
psychiatry? Encephale 43, 135–145. doi:10.1016/j.encep.2016.11.003.
Arns, M., Conners, C. K., and Kraemer, H. C. (2013). A decade of EEG theta/beta ratio research
in ADHD: A meta-analysis. J. Atten. Disord. 17, 374–383.
doi:10.1177/1087054712460087.
Arns, M., Heinrich, H., and Strehl, U. (2014). Evaluation of neurofeedback in ADHD: The long
and winding road. Biol. Psychol. 95, 108–115. doi:10.1016/j.biopsycho.2013.11.013.
Arns, M., and Kenemans, J. L. (2014). Neurofeedback in ADHD and insomnia: Vigilance
stabilization through sleep spindles and circadian networks. Neurosci. Biobehav. Rev.
44, 183–194. doi:10.1016/j.neubiorev.2012.10.006.
19

Arns, M., de Ridder, S., Strehl, U., Breteler, M., and Coenen, A. (2009). Efficacy of
neurofeedback treatment in ADHD: The effects on inattention, impulsivity and
hyperactivity: A meta-analysis. Clin. EEG Neurosci. 40, 180–189.
doi:10.1177/155005940904000311.
Barabasz, A., and Barabasz, M. (1996). “Neurotherapy and alert hypnosis in the treatment of
attention deficit hyperactivity disorder.,” in Casebook of Clinical Hypnosis., eds. S. J.
Lynn, I. Kirsch, and J. W. Rhue (Washington: American Psychological Association),
271–291. doi:10.1037/11090-013.
Barabasz, A., and Barabasz, M. (2000). Treating AD/HD with hypnosis and neurotherapy. Child
Study Journal 30, 25–32.
Barth, B., and Ehlis, A.-C. (2019). Neurofeedback in adult attention-deficit/hyperactivity disorder:
State of research and practical implications [Neurofeedback bei adulter
Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung: Stand der Forschung und Implikationen
für die Anwendung]. Psychotherapeut 64, 194–201. doi:10.1007/s00278-019-0350-4.
Bussalb, A., Congedo, M., Barthélemy, Q., Ojeda, D., Acquaviva, E., Delorme, R., and Mayaud,
L. (2019). Clinical and experimental factors influencing the efficacy of neurofeedback in
ADHD: A meta-analysis. Front. Psychiatry 10, 35. doi:10.3389/fpsyt.2019.00035.
Butnik, S. M. (2005). Neurofeedback in adolescents and adults with attention deficit
hyperactivity disorder. J. Clin. Psychol. 61, 621–625. doi:10.1002/jclp.20124.
Cortese, S., Ferrin, M., Brandeis, D., Holtmann, M., Aggensteiner, P., Daley, D., Santosh, P.,
Simonoff, E., Stevenson, J., Stringaris, A., et al. (2016). Neurofeedback for
attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological
outcomes from randomized controlled trials. J. Am. Acad. Child Adolesc. Psychiatry 55,
444–455. doi:10.1016/j.jaac.2016.03.007.
Enriquez-Geppert, S., Smit, D., Pimenta, M. G., and Arns, M. (2019). Neurofeedback as a
treatment intervention in ADHD: Current evidence and practice. Curr. Psychiatry Rep.
21, 46. doi:10.1007/s11920-019-1021-4.
Fox, D. J., Tharp, D. F., and Fox, L. C. (2005). Neurofeedback: An alternative and efficacious
treatment for attention deficit hyperactivity disorder. Appl. Psychophysiol. Biofeedback
30, 365–373. doi:10.1007/s10484-005-8422-3.
Gruzelier, J. (2009). A theory of alpha/theta neurofeedback, creative performance
enhancement, long distance functional connectivity and psychological integration. Cogn.
Process. 10 Suppl 1, S101-9. doi:10.1007/s10339-008-0248-5.
20

Gruzelier, J., and Egner, T. (2005). Critical validation studies of neurofeedback. Child Adolesc.
Psychiatr. Clin. N. Am. 14, 83–104, vi. doi:10.1016/j.chc.2004.07.002.
Gruzelier, J., Egner, T., and Vernon, D. (2006). “Validating the efficacy of neurofeedback for
optimising performance,” in Event-Related Dynamics of Brain Oscillations Progress in
Brain Research. (Elsevier), 421–431. doi:10.1016/S0079-6123(06)59027-2.
Hirshberg, L. M. (2007). Place of electroencephalograpic biofeedback for
attention-deficit/hyperactivity disorder. Expert Rev. Neurother. 7, 315–319.
doi:10.1586/14737175.7.4.315.
Hodgson, K., Hutchinson, A. D., and Denson, L. (2014). Nonpharmacological treatments for
ADHD: A meta-analytic review. J. Atten. Disord. 18, 275–282.
doi:10.1177/1087054712444732.
Holtmann, M., Stadler, C., Leins, U., Strehl, U., Birbaumer, N., and Poustka, F. (2004).
Neurofeedback for the treatment of attention-deficit/hyperactivity disorder (ADHD) in
childhood and adolescence. Zeitschrift für Kinder- und Jugendpsychiatrie und
Psychotherapie 32, 187–200. doi:10.1024/1422-4917.32.3.187.
Kirk, L. (2007). “Neurofeedback protocols for subtypes of attention deficit/hyperactivity disorder,”
in Handbook of neurofeedback: dynamics and clinical applications, ed. J. Evans (CRC
Press), 267–300. doi:10.1201/b14658-16.
Krell, J., Todd, A., and Dolecki, P. K. (2019). Bridging the gap between theory and practice in
neurofeedback training for attention. Mind Brain Education 13, 246–260.
doi:10.1111/mbe.12220.
La Marca, J. P. (2017). Historical overview of attention deficit-hyperactivity disorder and
neurofeedback: Implications for academic achievement, assessment, and intervention in
schools. Contemp. Sch. Psychol. 22, 1–17. doi:10.1007/s40688-017-0155-9.
Lambez, B., Harwood-Gross, A., Golumbic, E. Z., and Rassovsky, Y. (2020).
Non-pharmacological interventions for cognitive difficulties in ADHD: A systematic review
and meta-analysis. J. Psychiatr. Res. 120, 40–55. doi:10.1016/j.jpsychires.2019.10.007.
Lofthouse, N., Arnold, L. E., Hersch, S., Hurt, E., and DeBeus, R. (2012). A review of
neurofeedback treatment for pediatric ADHD. J. Atten. Disord. 16, 351–372.
doi:10.1177/1087054711427530.
Loo, S. K., and Barkley, R. A. (2005). Clinical utility of EEG in attention deficit hyperactivity
disorder. Appl. Neuropsychol. 12, 64–76. doi:10.1207/s15324826an1202_2.
21

Lubar, J. F. (1991). Discourse on the development of EEG diagnostics and biofeedback for
attention-deficit/hyperactivity disorders. Biofeedback Self Regul. 16, 201–225.
doi:10.1007/BF01000016.
Lubar, J. F. (1997). Neocortical dynamics: Implications for understanding the role of
neurofeedback and related techniques for the enhancement of attention. Applied
Psychophysiology and Biofeedback 22, 111–126.
Lubar, J. F. (2003). “Neurofeedback for the management of attention deficit disorders,” in
Biofeedback: A Practitioner’s Guide, eds. M. S. Schwartz and F. Andrasik (New York:
Guilford Press), 409–437.
Lubar, J. F. (1995). “Neurofeedback for the management of attention-deficit/hyperactivity
disorders,” in Biofeedback: A Practitioner’s Guide, ed. M. S. Schwartz (New York: The
Guilford Press), 493–522.
Micoulaud-Franchi, J. A., McGonigal, A., Lopez, R., Daudet, C., Kotwas, I., and Bartolomei, F.
(2015). Electroencephalographic neurofeedback: Level of evidence in mental and brain
disorders and suggestions for good clinical practice. Neurophysiol. Clin. 45, 423–433.
doi:10.1016/j.neucli.2015.10.077.
Micoulaud-Franchi, J.-A., Geoffroy, P. A., Fond, G., Lopez, R., Bioulac, S., and Philip, P. (2014).
EEG neurofeedback treatments in children with ADHD: An updated meta-analysis of
randomized controlled trials. Front. Hum. Neurosci. 8, 906.
doi:10.3389/fnhum.2014.00906.
Monastra, V. J. (2005). Electroencephalographic biofeedback (neurotherapy) as a treatment for
attention deficit hyperactivity disorder: Rationale and empirical foundation. Child
Adolesc. Psychiatr. Clin. N. Am. 14, 55–82, vi. doi:10.1016/j.chc.2004.07.004.
Moriyama, T. S., Polanczyk, G., Caye, A., Banaschewski, T., Brandeis, D., and Rohde, L. A.
(2012). Evidence-based information on the clinical use of neurofeedback for ADHD.
Neurotherapeutics 9, 588–598. doi:10.1007/s13311-012-0136-7.
Narimani, M., Ensafi, E., and Mohajeri Aval, N. (2018). Effectiveness of neurofeedback
treatment on adult ADHD: A meta-analysis. PCP 6, 73–82.
doi:10.29252/nirp.jpcp.6.2.73.
Nash, J. K. (2000). Treatment of attention deficit hyperactivity disorder with neurotherapy. Clin
Electroencephalogr 31, 30–37. doi:10.1177/155005940003100109.
Ordikhani-Seyedlar, M., and Lebedev, M. A. (2017). “Controlling attention with neurofeedback,”
in The Physics of the Mind and Brain Disorders Springer Series in Cognitive and Neural
22

Systems., eds. I. Opris and M. F. Casanova (Cham: Springer International Publishing),
545–572. doi:10.1007/978-3-319-29674-6_25.
Pigott, H. E., and Cannon, R. (2014a). Neurofeedback is the best available first-line treatment
for ADHD: What is the evidence for this claim? NeuroRegulation 1, 4–23.
doi:10.15540/nr.1.1.4.
Pigott, H. E., and Cannon, R. (2014b). Neurofeedback requires better evidence of efficacy
before it should be considered a legitimate treatment for ADHD: What is the evidence for
this claim? NeuroRegulation 1, 25–45. doi:10.15540/nr.1.1.25.
Pigott, H. E., Cannon, R., and Trullinger, M. (2018). The fallacy of sham-controlled
neurofeedback trials: A reply to Thibault and colleagues (2018). J. Atten. Disord.,
1087054718790802. doi:10.1177/1087054718790802.
Razoki, B. (2018). Neurofeedback versus psychostimulants in the treatment of children and
adolescents with attention-deficit/hyperactivity disorder: A systematic review.
Neuropsychiatr. Dis. Treat. 14, 2905–2913. doi:10.2147/NDT.S178839.
Riesco-Matías, P., Yela-Bernabé, J. R., Crego, A., and Sánchez-Zaballos, E. (2019). What do
meta-analyses have to say about the efficacy of neurofeedback applied to children with
ADHD? Review of previous meta-analyses and a new meta-analysis. J. Atten. Disord.,
1087054718821731. doi:10.1177/1087054718821731.
Ros, T., J Baars, B., Lanius, R. A., and Vuilleumier, P. (2014). Tuning pathological brain
oscillations with neurofeedback: A systems neuroscience framework. Front. Hum.
Neurosci. 8, 1008. doi:10.3389/fnhum.2014.01008.
Rossiter, T. (2004). The effectiveness of neurofeedback and stimulant drugs in treating AD/HD:
Part I. Review of methodological issues. Appl. Psychophysiol. Biofeedback 29, 95–112.
doi:10.1023/B:APBI.0000026636.13180.b6.
Ryana, M., Brownb, T., Vollebregtc, M. A., and Arnse, M. (2019). What’s sleep got to do with it?
Circadian rhythm sleep disorder, ADHD and neurofeedback. APJNT 1, 85–98.
Sherlin, L., Arns, M., Lubar, J., and Sokhadze, E. (2010). A position paper on neurofeedback for
the treatment of ADHD. J. Neurother. 14, 66–78. doi:10.1080/10874201003773880.
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M.,
Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013).
Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of
randomized controlled trials of dietary and psychological treatments. Am. J. Psychiatry
170, 275–289. doi:10.1176/appi.ajp.2012.12070991.
23

Stankus, T. (2008). Can the brain be trained? Comparing the literature on the use of EEG
biofeedback/neurofeedback as an alternative or complementary therapy for attention
deficit hyperactivity disorder (ADHD). Behav. Soc. Sci. Librar. 26, 20–56.
doi:10.1080/01639260802031556.
Thompson, M., and Thompson, L. (2015). The Neurofeedback Book: An Introduction to Basic
Concepts in Applied Psychophysiology. 2nd ed. Wheat Ridge, CO: The Association for
Applied Psychophysiology and Biofeedback.
Van Doren, J., Arns, M., Heinrich, H., Vollebregt, M. A., Strehl, U., and K Loo, S. (2019).
Sustained effects of neurofeedback in ADHD: A systematic review and meta-analysis.
Eur. Child Adolesc. Psychiatry 28, 293–305. doi:10.1007/s00787-018-1121-4.
Vernon, D., Dempster, T., Bazanova, O., Rutterford, N., Pasqualini, M., and Andersen, S.
(2009). Alpha neurofeedback training for performance enhancement: Reviewing the
methodology. J. Neurother. 13, 214–227. doi:10.1080/10874200903334397.
Vernon, D., Frick, A., and Gruzelier, J. (2004). Neurofeedback as a treatment for ADHD: A
methodological review with implications for future research. J. Neurother. 8, 53–82.
doi:10.1300/J184v08n02_04.
Vernon, D. J. (2005). Can neurofeedback training enhance performance? An evaluation of the
evidence with implications for future research. Appl. Psychophysiol. Biofeedback 30,
347–364. doi:10.1007/s10484-005-8421-4.
Vollebregt, M. A., van Dongen-Boomsma, M., Buitelaar, J. K., and Slaats-Willemse, D. (2014).
Does EEG-neurofeedback improve neurocognitive functioning in children with
attention-deficit/hyperactivity disorder? A systematic review and a double-blind
placebo-controlled study. J. Child Psychol. Psychiatry 55, 460–472.
doi:10.1111/jcpp.12143.
Williams, J. M. (2010). Does neurofeedback help reduce attention-deficit hyperactivity disorder?
J. Neurother. 14, 261–279. doi:10.1080/10874208.2010.523331.
Yan, L., Wang, S., Yuan, Y., and Zhang, J. (2019). Effects of neurofeedback versus
methylphenidate for the treatment of ADHD: Systematic review and meta-analysis of
head-to-head trials. Evid. Based Ment. Health 22, 111–117.
doi:10.1136/ebmental-2019-300088.
24

Addictive Disorders
STUDIES
Burkett, V. S., Cummins, J. M., Dickson, R. M., and Skolnick, M. (2005). An open clinical trial
utilizing real-time EEG operant conditioning as an adjunctive therapy in the treatment of
crack cocaine dependence. J. Neurother. 9, 27–47. doi:10.1300/J184v09n02_03.
Callaway, T. G., and Bodenhamer-Davis, E. (2008). Long-term follow-up of a clinical replication
of the Peniston protocol for chemical dependency. J. Neurother. 12, 243–259.
doi:10.1080/10874200802502060.
Dalkner, N., Unterrainer, H. F., Wood, G., Skliris, D., Holasek, S. J., Gruzelier, J. H., and
Neuper, C. (2017). Short-term beneficial effects of 12 sessions of neurofeedback on
avoidant personality accentuation in the treatment of alcohol use disorder. Front.
Psychol. 8, 1688. doi:10.3389/fpsyg.2017.01688.
Dehghani-Arani, F., Rostami, R., and Nadali, H. (2013). Neurofeedback training for opiate
addiction: Improvement of mental health and craving. Appl. Psychophysiol. Biofeedback
38, 133–141. doi:10.1007/s10484-013-9218-5.
Dehghani-Arani, F., Rostami, R., and Nostratabadi, M. (2010). Effectiveness of neurofeedback
training as a treatment for opioid-dependent patients. Clin. EEG Neurosci. 41, 170–177.
doi:10.1177/155005941004100313.
Fielenbach, S., Donkers, F. C. L., Spreen, M., and Bogaerts, S. (2019). The ability of forensic
psychiatric patients with substance use disorder to learn neurofeedback. Int. J. Forensic
Ment. Health 18, 187–199. doi:10.1080/14999013.2018.1485187.
Fielenbach, S., Donkers, F. C., Spreen, M., and Bogaerts, S. (2018). Effects of a
theta/sensorimotor rhythm neurofeedback training protocol on measures of impulsivity,
drug craving, and substance abuse in forensic psychiatric patients with substance
abuse: Randomized controlled trial. JMIR Ment Health 5, e10845. doi:10.2196/10845.
Hashemian, P. (2015). The effectiveness of neurofeedback therapy in craving of
methamphetamine use. Open J. Psychiatr. 05, 177–179.
doi:10.4236/ojpsych.2015.52020.
Horrell, T., El-Baz, A., Baruth, J., Tasman, A., Sokhadze, G., Stewart, C., and Sokhadze, E.
(2010). Neurofeedback effects on evoked and induced EEG gamma band reactivity to
25

drug-related cues in cocaine addiction. J. Neurother. 14, 195–216.
doi:10.1080/10874208.2010.501498.
Keith, J. R., Rapgay, L., Theodore, D., Schwartz, J. M., and Ross, J. L. (2015). An assessment
of an automated EEG biofeedback system for attention deficits in a substance use
disorders residential treatment setting. Psychol. Addict. Behav. 29, 17–25.
doi:10.1037/adb0000016.
Kelley, M. J. (1997). “Native Americans, neurofeedback, and substance abuse theory”. Three
year outcome of alpha/theta neurofeedback training in the treatment of problem drinking
among Dine’ (Navajo) people. J. Neurother. 2, 24–60. doi:10.1300/J184v02n03_03.
Lackner, N., Unterrainer, H. F., Skliris, D., Wood, G., Wallner-Liebmann, S. J., Neuper, C., and
Gruzelier, J. H. (2016). The effectiveness of visual short-time neurofeedback on brain
activity and clinical characteristics in alcohol use disorders: Practical issues and results.
Clin. EEG Neurosci. 47, 188–195. doi:10.1177/1550059415605686.
Peniston, E. G., and Kulkosky, P. J. (1989). Alpha-theta brainwave training and beta-endorphin
levels in alcoholics. Alcohol. Clin. Exp. Res. 13, 271–279.
doi:10.1111/j.1530-0277.1989.tb00325.x.
Peniston, E. G., and Kulkosky, P. J. (1990). Alcoholic personality and alpha-theta brainwave
training. Medical Psychotherapy: An International Journal 3, 37–55.
Rostami, R., and Dehghani-Arani, F. (2015). Neurofeedback training as a new method in
treatment of crystal methamphetamine dependent patients: A preliminary study. Appl.
Russo, G., and Novian, D. A. (2014). A research analysis of neurofeedback protocols for PTSD
and alcoholism. NR 1, 183–186. doi:10.15540/nr.1.2.183.
Saxby, E., and Peniston, E. G. (1995). Alpha-theta brainwave neurofeedback training: An
effective treatment for male and female alcoholics with depressive symptoms. J. Clin.
Psychol. 51, 685–693.
doi:10.1002/1097-4679(199509)51:5<685::AID-JCLP2270510514>3.0.CO;2-K.
Scott, W. C., Kaiser, D., Othmer, S., and Sideroff, S. I. (2005). Effects of an EEG biofeedback
protocol on a mixed substance abusing population. Am. J. Drug Alcohol Abuse 31,
455–469. doi:10.1081/ada-200056807.
Scott, W., and Kaiser, D. (1998). Augmenting chemical dependency treatment with
neurofeedback training. Journal of Neurotherapy 3, 66.
26

Trudeau, D. L. (2008). Brainwave biofeedback for addictive disorder. J. Neurother. 12, 181–183.
doi:10.1080/10874200802502391.
Tuab, E., Steiner, S. S., Weingarten, E., and Walton, K. G. (1994). Effectiveness of broad
spectrum approaches to relapse prevention in severe alcoholism: A long-term,
randomized, controlled trial of transcendental meditiation, EMG biofeedback and
electronic neurotherapy. Alcohol. Treat. Q. 11, 187–220. doi:10.1300/J020v11n01_06.
CASE REPORTS
Unterrainer, H. F., Chen, M. J. L., and Gruzelier, J. H. (2014). EEG-neurofeedback and
psychodynamic psychotherapy in a case of adolescent anhedonia with substance
misuse: mood/theta relations. Int. J. Psychophysiol. 93, 84–95.
doi:10.1016/j.ijpsycho.2013.03.011.
REVIEWS
doi:10.1016/j.neucli.2015.10.077.
Schmidt, J., Kärgel, C., and Opwis, M. (2017). Neurofeedback in substance use and overeating:
Current applications and future directions. Curr. Addict. Rep. 4, 116–131.
doi:10.1007/s40429-017-0137-z.
Sokhadze, T. M., Cannon, R. L., and Trudeau, D. L. (2008). EEG biofeedback as a treatment for
substance use disorders: Review, rating of efficacy, and recommendations for further
research. Appl. Psychophysiol. Biofeedback 33, 1–28. doi:10.1007/s10484-007-9047-5.
Sokhadze, T. M., Stewart, C. M., and Hollifield, M. (2007). Integrating cognitive neuroscience
research and cognitive behavioral treatment with neurofeedback Therapy in drug
addiction comorbid with posttraumatic stress disorder: A conceptual review. J.
27

Sunder, K. R., and Bohnen, J. L. (2017). The progression of neurofeedback: An evolving
paradigm in addiction treatment and relapse prevention. MOJAMT 3, 75–78.
doi:10.15406/mojamt.2017.03.00037.
Trudeau, D. L. (2005). Applicability of brain wave biofeedback to substance use disorder in
adolescents. Child Adolesc. Psychiatr. Clin. N. Am. 14, 125–36, vii.
doi:10.1016/j.chc.2004.07.006.
Anxiety
STUDIES
Agnihotri, H., Paul, M., and Sandhu, J. S. (2007). Biofeedback approach in the treatment of
generalized anxiety disorder. Iranian Journal of Psychiatry 2, 90–95. Available at:
http://ijps.tums.ac.ir/index.php/ijps/article/view/444 [Accessed March 17, 2020].
Agnihotri, H., Paul, M., and Sandhu, J. S. (2008). The comparative efficacy of two biofeedback
techniques in the treatment of generalized anxiety disorder. Pakistan Journal of Social
and Clinical Psychology 6, 35–46.
Coger, R., and Werbach, M. (1975). Attention, anxiety and the effects of learned enhancement
of EEG alpha in chronic pain: A pilot study in biofeedback. Pain Research and
Treatment, 297–303.
Dadashi, M., Birashk, B., Taremian, F., Asgarnejad, A. A., and Momtazi, S. (2015). Effects of
increase in amplitude of occipital alpha & theta brain waves on global functioning level of
patients with GAD. Basic Clin. Neurosci. 6, 14–20.
Egner, T., and Gruzelier, J. H. (2003). Ecological validity of neurofeedback: Modulation of slow
wave EEG enhances musical performance. Neuroreport 14, 1221–1224.
doi:10.1097/01.wnr.0000081875.45938.d1.
Garrett, B. L., and Silver, M. P. (1976). “The use of EMG and alpha biofeedback to relieve test
anxiety in college students,” in Biofeedback, Behavior Therapy, and Hypnosis, ed. I.
Wickramasekera (Chicago: Nelson–Hall).
28

Hardt, J. V., and Kamiya, J. (1978). Anxiety change through electroencephalographic alpha
feedback seen only in high anxiety subjects. Science 201, 79–81.
doi:10.1126/science.663641.
Holmes, D. S., Burish, T. G., and Frost, R. O. (1980). Effects of instructions and biofeedback on
EEG-alpha production and the effects of EEG-alpha biofeedback training for controlling
arousal in a subsequent stressful situation. J. Res. Pers. 14, 212–223.
doi:10.1016/0092-6566(80)90029-X.
Hsueh, J.-J., Chen, T.-S., Chen, J.-J., and Shaw, F.-Z. (2016). Neurofeedback training of EEG
alpha rhythm enhances episodic and working memory. Hum. Brain Mapp. 37,
2662–2675. doi:10.1002/hbm.23201.
Huang-Storms, L., Bodenhamer-Davis, E., Davis, R., and Dunn, J. (2007). QEEG-guided
neurofeedback for children with histories of abuse and neglect: Neurodevelopmental
rationale and pilot study. J. Neurother. 10, 3–16. doi:10.1300/J184v10n04_02.
Kayiran, S., Dursun, E., Ermutlu, N., Dursun, N., and Karamürsel, S. (2007). Neurofeedback in
fibromyalgia syndrome. Agri 19, 47–53.
Keller, I. (2001). Neurofeedback therapy of attention deficits in patients with traumatic brain
injury. J. Neurother. 5, 19–32. doi:10.1300/J184v05n01_03.
Lu, Y., Wang, C., Su, L., Ma, Z., Li, S., and Fan, Y. (2017). Effects of neurofeedback on panic
disorder patients’ anxiety. Neuroquantology 15, 172–178.
doi:10.14704/nq.2017.15.3.1083.
Peper, E., Lee, S., Harvey, R., and Lin, I.-M. (2016). Breathing and math performance:
Implications for performance and neurotherapy. NR 3, 142–149.
doi:10.15540/nr.3.4.142.
Rice, K. M., Blanchard, E. B., and Purcell, M. (1993). Biofeedback treatments of generalized
anxiety disorder: Preliminary results. Biofeedback Self Regul. 18, 93–105.
doi:10.1007/bf01848110.
Psychol. 51, 685–693.
doi:10.1002/1097-4679(199509)51:5<685::AID-JCLP2270510514>3.0.CO;2-K.
Schoneveld, E. A., Malmberg, M., Lichtwarck-Aschoff, A., Verheijen, G. P., Engels, R. C. M. E.,
and Granic, I. (2016). A neurofeedback video game (MindLight) to prevent anxiety in
29

children: A randomized controlled trial. Comput. Human Behav. 63, 321–333.
doi:10.1016/j.chb.2016.05.005.
Thompson, M., and Thompson, L. (2006). Improving attention in adults and children: Differing
electroencephalography profiles and implications for training. Biofeedback 34, 99–105.
Tsatali, M., Sidiropoulos, S., and Bamidis, P. (2019). Effective neurofeedback applications in
anxiety and attention symptomatology in adolescents. L’Encéphale 45, S80.
doi:10.1016/j.encep.2019.04.041.
Vanathy, S., Sharma, P. S., and Kumar, K. B. (1998). The efficacy of alpha and theta
neurofeedback training in treatment of generalized anxiety disorder. Indian Journal of
Clinical Psychology 25, 136–143.
Wang, S., Zhao, Y., Chen, S., Lin, G., Sun, P., and Wang, T. (2013). EEG biofeedback
improves attentional bias in high trait anxiety individuals. BMC Neurosci. 14, 115.
doi:10.1186/1471-2202-14-115.
Watson, C. G., Herder, J., and Passini, F. T. (1978). Alpha biofeedback therapy in alcoholics:
An 18-month follow-up. J. Clin. Psychol. 34, 765–769.
doi:10.1002/1097-4679(197807)34:3<765::aid-jclp2270340339>3.0.co;2-5.
White, E. K., Groeneveld, K. M., Tittle, R. K., Bolhuis, N. A., Martin, R. E., Royer, T. G., and
Fotuhi, M. (2017). Combined neurofeedback and heart rate variability training for
individuals with symptoms of anxiety and depression: A retrospective study. NR 4,
37–55. doi:10.15540/nr.4.1.37.
Zhang, P., and Cheng, L. (2017). A randomized controlled trial of a neurofeedback-based
training for improvement in social phobia disorder. Neuroquantology 15.
doi:10.14704/nq.2017.15.4.1136.
CASE REPORTS
Askovic, M., Watters, A. J., Aroche, J., and Harris, A. W. F. (2017). Neurofeedback as an
adjunct therapy for treatment of chronic posttraumatic stress disorder related to refugee
trauma and torture experiences: Two case studies. Australas. Psychiatry 25, 358–363.
doi:10.1177/1039856217715988.
Moradi, A., Pouladi, F., Pishva, N., Rezaei, B., Torshabi, M., and Mehrjerdi, Z. A. (2011).
Treatment of anxiety disorder with neurofeedback: Case study. Procedia - Social and
Behavioral Sciences 30, 103–107. doi:10.1016/j.sbspro.2011.10.021.
30

Rozelle, G. R., and Budzynski, T. H. (1995). Neurotherapy for stroke rehabilitation: A single
case study. Biofeedback Self Regul. 20, 211–228. doi:10.1007/bf01474514.
Thomas, J. E., and Sattlberger, E. (1997). Treatment of chronic anxiety disorder with
neurotherapy. J. Neurother. 2, 14–19. doi:10.1300/J184v02n02_03.
REVIEWS
Hammond, D. C. (2005a). Neurofeedback with anxiety and affective disorders. Child Adolesc.
Psychiatr. Clin. N. Am. 14, 105–23, vii. doi:10.1016/j.chc.2004.07.008.
Hammond, D. C. (2005b). Neurofeedback treatment of depression and anxiety. J. Adult Dev.
12, 131–137. doi:10.1007/s10804-005-7029-5.
Hirshberg, L. M. (2007). Place of electroencephalograpic biofeedback for
attention-deficit/hyperactivity disorder. Expert Rev. Neurother. 7, 315–319.
doi:10.1586/14737175.7.4.315.
doi:10.1016/j.neucli.2015.10.077.
Moore, N. C. (2000). A review of EEG biofeedback treatment of anxiety disorders. Clinical
Electroencephalography 31, 1–6. doi:10.1177/155005940003100105.
Tolin, D. F., Davies, C. D., Moskow, D. M., and Hofmann, S. G. (2020). Biofeedback and
neurofeedback for anxiety disorders: A quantitative and qualitative systematic review.
Adv. Exp. Med. Biol. 1191, 265–289. doi:10.1007/978-981-32-9705-0_16.
31

Autism Spectrum Disorders (ASD)
STUDIES
Coben, R., and Padolsky, I. (2007). Assessment-guided neurofeedback for autistic spectrum
disorder. J. Neurother. 11, 5–23. doi:10.1300/J184v11n01_02.
Datko, M., Pineda, J. A., and Müller, R.-A. (2018). Positive effects of neurofeedback on autism
symptoms correlate with brain activation during imitation and observation. Eur. J.
Neurosci. 47, 579–591. doi:10.1111/ejn.13551.
Drysdale, M. T. B., Martinez, Y. J., and Thompson, L. (2012). The effects of humorous literature
on emotion: A pilot project comparing children with Asperger’s syndrome before and
after neurofeedback training and controls. J. Neurother. 16, 196–209.
doi:10.1080/10874208.2012.705758.
Friedrich, E. V. C., Sivanathan, A., Lim, T., Suttie, N., Louchart, S., Pillen, S., and Pineda, J. A.
(2015). An effective neurofeedback intervention to improve social interactions in children
with autism spectrum disorder. J. Autism Dev. Disord. 45, 4084–4100.
doi:10.1007/s10803-015-2523-5.
Jarusiewicz, B. (2002). Efficacy of neurofeedback for children in the autistic spectrum: A pilot
study. J. Neurother. 6, 39–49. doi:10.1300/J184v06n04_05.
Knezevic, B., Thompson, L., and Thompson, M. (2010). Pilot project to ascertain the utility of
Tower of London test to assess outcomes of neurofeedback in clients with Asperger’s
syndrome. J. Neurother. 14, 3–19. doi:10.1080/10874200903543922.
Kouijzer, M. E. J., de Moor, J. M. H., Gerrits, B. J. L., Buitelaar, J. K., and van Schie, H. T.
(2009). Long-term effects of neurofeedback treatment in autism. Res. Autism Spectr.
Disord. 3, 496–501. doi:10.1016/j.rasd.2008.10.003.
Pineda, J. A., Brang, D., Hecht, E., Edwards, L., Carey, S., Bacon, M., Futagaki, C., Suk, D.,
Tom, J., Birnbaum, C., et al. (2008). Positive behavioral and electrophysiological
changes following neurofeedback training in children with autism. Res. Autism Spectr.
Disord. 2, 557–581. doi:10.1016/j.rasd.2007.12.003.
Ryan, A., and Files, N. (2019). The efficacy of neurofeedback and traditional therapies with
autism spectrum disorder in a clinic setting. APJN 1, 14–20.
32

Steiner, N. J., Frenette, E., Hynes, C., Pisarik, E., Tomasetti, K., Perrin, E. C., and Rene, K.
(2014). A pilot feasibility study of neurofeedback for children with autism. Appl.
Wang, Y., Sokhadze, E. M., El-Baz, A. S., Li, X., Sears, L., Casanova, M. F., and Tasman, A.
(2015). Relative power of specific EEG bands and their ratios during neurofeedback
training in children with autism spectrum disorder. Front. Hum. Neurosci. 9, 723.
doi:10.3389/fnhum.2015.00723.
CASE REPORTS
Legarda, S. B., McMahon, D., Othmer, S., and Othmer, S. (2011). Clinical neurofeedback: Case
studies, proposed mechanism, and implications for pediatric neurology practice. J. Child
Neurol. 26, 1045–1051. doi:10.1177/0883073811405052.
Sichel, A. G., Fehmi, L. G., and Goldstein, D. M. (1995). Positive outcome with neurofeedback
treatment in a case of mild autism. J. Neurother. 1, 60–64. doi:10.1300/J184v01n01_08.
REVIEWS
Coben, R. (2013). “Neurofeedback for autistic disorders: Emerging empirical evidence,” in
Imaging the Brain in Autism, eds. M. F. Casanova, A. S. El-Baz, and J. S. Suri (New
York, NY: Springer New York), 107–134. doi:10.1007/978-1-4614-6843-1_6.
Frye, R. E., Rossignol, D., Casanova, M. F., Brown, G. L., Martin, V., Edelson, S., Coben, R.,
Lewine, J., Slattery, J. C., Lau, C., et al. (2013). A review of traditional and novel
treatments for seizures in autism spectrum disorder: Findings from a systematic review
and expert panel. Front. Public Health 1, 31. doi:10.3389/fpubh.2013.00031.
Jarusiewicz, B. (2007). “Use of neurofeedback with autistic spectrum disorders,” in Handbook of
Neurofeedback: Dynamics and Clinical Applications, ed. J. Evans (CRC Press),
321–340. doi:10.1201/b14658-18.
doi:10.1016/j.neucli.2015.10.077.
33

Chronic Fatigue Syndrome and Fibromyalgia
STUDIES
Billiot, K. M., Budzynski, T. H., and Andrasik, F. (1997). EEG patterns and chronic fatigue
syndrome. J. Neurother. 2, 20–30. doi:10.1300/J184v02n02_04.
CASE REPORTS
Hammond, D. C. (2001). Treatment of chronic fatigue with neurofeedback and self-hypnosis.
NeuroRehabilitation 16, 295–300.
James, L. C., and Folen, R. A. (1996). EEG biofeedback as a treatment for chronic fatigue
syndrome: a controlled case report. Behav. Med. 22, 77–81.
doi:10.1080/08964289.1996.9933767.
Kayiran, S., Dursun, E., Ermutlu, N., Dursun, N., and Karamürsel, S. (2007). Neurofeedback in
fibromyalgia syndrome. Agri 19, 47–53.
REVIEWS
Tansey, M. (1993). EEG neurofeedback and chronic fatigue syndrome: New findings with
respect to diagnosis and treatment. The CFIDS Chronicle, 30 32.
34

Cognitive Decline
Note: These references include studies relevant to individuals identified as having cognitive
decline or studies in healthy adults with direct implications for adults with cognitive decline.
For studies relevant to enhancing cognitive function in healthy individuals, see the separate
Peak Performance bibliography.
STUDIES
Berman, M. H., and Frederick, J. A. (2009). Efficacy of neurofeedback for executive and
memory function in dementia. Alzheimers Dement 5, e8. doi:10.1016/j.jalz.2009.07.046.
Bielas, J., and Michalczyk, Ł. (2020). Beta neurofeedback training improves attentional control
in the elderly. Psychol. Rep., 33294119900348. doi:10.1177/0033294119900348.
Bobori, C., and Plerou, A. (2019). Memory enhancement with the use of neurofeedback and
CVLT repetition techniques in the case of anterograde amnesia. J Neurosci Neurosurg
2.
Budzynski, H., and Tang, H.-Y. (2007). “Brain brightening: Restoring the aging mind,” in
Handbook of Neurofeedback: Dynamics and Clinical Applications, ed. J. Evans (CRC
Press), 231–265. doi:10.1201/b14658-15.
Campos da Paz, V. K., Garcia, A., Campos da Paz Neto, A., and Tomaz, C. (2018). SMR
neurofeedback training facilitates working memory performance in healthy older adults:
A behavioral and EEG study. Front. Behav. Neurosci. 12, 321.
doi:10.3389/fnbeh.2018.00321.
Fotuhi, M., Lubinski, B., Trullinger, M., Hausterman, N., Riloff, T., Hadadi, M., and Raji, C. A.
(2016). A personalized 12-week “Brain Fitness Program” for improving cognitive function
and increasing the volume of hippocampus in elderly with mild cognitive impairment. J
Prev Alzheimers Dis 3, 133–137. doi:10.14283/jpad.2016.92.
Geladé, K., Janssen, T. W. P., Bink, M., Twisk, J. W. R., van Mourik, R., Maras, A., and
Oosterlaan, J. (2018). A 6-month follow-up of an RCT on behavioral and neurocognitive
effects of neurofeedback in children with ADHD. Eur. Child Adolesc. Psychiatry 27,
581–593. doi:10.1007/s00787-017-1072-1.
Gomez-Pilar, J., Corralejo, R., Nicolas-Alonso, L. F., Álvarez, D., and Hornero, R. (2016).
Neurofeedback training with a motor imagery-based BCI: Neurocognitive improvements
35

and EEG changes in the elderly. Med. Biol. Eng. Comput. 54, 1655–1666.
doi:10.1007/s11517-016-1454-4.
Jang, J.-H., Kim, J., Park, G., Kim, H., Jung, E.-S., Cha, J.-Y., Kim, C.-Y., Kim, S., Lee, J.-H.,
and Yoo, H. (2019). Beta wave enhancement neurofeedback improves cognitive
functions in patients with mild cognitive impairment: A preliminary pilot study. Medicine
(Baltimore) 98, e18357. doi:10.1097/MD.0000000000018357.
Jirayucharoensak, S., Israsena, P., Pan-Ngum, S., Hemrungrojn, S., and Maes, M. (2019). A
game-based neurofeedback training system to enhance cognitive performance in
healthy elderly subjects and in patients with amnestic mild cognitive impairment. Clin.
Interv. Aging 14, 347–360. doi:10.2147/CIA.S189047.
Keune, P. M., Hansen, S., Sauder, T., Jaruszowic, S., Kehm, C., Keune, J., Weber, E.,
Schönenberg, M., and Oschmann, P. (2019). Frontal brain activity and cognitive
processing speed in multiple sclerosis: An exploration of EEG neurofeedback training.
Neuroimage Clin. 22, 101716. doi:10.1016/j.nicl.2019.101716.
Kober, S. E., Pinter, D., Enzinger, C., Damulina, A., Duckstein, H., Fuchs, S., Neuper, C., and
Wood, G. (2019). Self-regulation of brain activity and its effect on cognitive function in
patients with multiple sclerosis - First insights from an interventional study using
neurofeedback. Clin. Neurophysiol. 130, 2124–2131. doi:10.1016/j.clinph.2019.08.025.
Kober, S. E., Schweiger, D., Reichert, J. L., Neuper, C., and Wood, G. (2017). Upper alpha
based neurofeedback training in chronic stroke: Brain plasticity processes and cognitive
effects. Appl. Psychophysiol. Biofeedback 42, 69–83. doi:10.1007/s10484-017-9353-5.
Kober, S. E., Schweiger, D., Witte, M., Reichert, J. L., Grieshofer, P., Neuper, C., and Wood, G.
(2015). Specific effects of EEG based neurofeedback training on memory functions in
post-stroke victims. J. Neuroeng. Rehabil. 12, 107. doi:10.1186/s12984-015-0105-6.
Lavy, Y., Dwolatzky, T., Kaplan, Z., Guez, J., and Todder, D. (2019). Neurofeedback improves
memory and peak alpha frequency in individuals with mild cognitive impairment. Appl.
Luijmes, R. E., Pouwels, S., and Boonman, J. (2016). The effectiveness of neurofeedback on
cognitive functioning in patients with Alzheimer’s disease: Preliminary results.
Neurophysiol. Clin. 46, 179–187. doi:10.1016/j.neucli.2016.05.069.
Marlats, F., Djabelkhir-Jemmi, L., Azabou, E., Boubaya, M., Pouwels, S., and Rigaud, A.-S.
(2019). Comparison of effects between SMR/delta-ratio and beta1/theta-ratio
36

neurofeedback training for older adults with mild cognitive impairment: A protocol for a
randomized controlled trial. Trials 20, 88. doi:10.1186/s13063-018-3170-x.
McReynolds, C., Villalpando, L., and Britt, C. (2018). Using neurofeedback to improve ADHD
symptoms in school-aged children. NR 5, 109–128. doi:10.15540/nr.5.4.109.
Morales-Quezada, L., Martinez, D., El-Hagrassy, M. M., Kaptchuk, T. J., Sterman, M. B., and
Yeh, G. Y. (2019). Neurofeedback impacts cognition and quality of life in pediatric focal
epilepsy: An exploratory randomized double-blinded sham-controlled trial. Epilepsy
Behav. 101, 106570. doi:10.1016/j.yebeh.2019.106570.
Nan, W., Rodrigues, J. P., Ma, J., Qu, X., Wan, F., Mak, P.-I., Mak, P. U., Vai, M. I., and Rosa,
A. (2012). Individual alpha neurofeedback training effect on short term memory. Int. J.
Psychophysiol. 86, 83–87. doi:10.1016/j.ijpsycho.2012.07.182.
Sarvghadi, P., Ghaffari, A., and Rostami, H. R. (2019). The effects of neurofeedback training on
short-term memory and quality of life in women with breast cancer. Int. J. Ther. Rehabil.
26, 1–8. doi:10.12968/ijtr.2018.0088.
Shereena, E. A., Gupta, R. K., Bennett, C. N., Sagar, K. J. V., and Rajeswaran, J. (2019). EEG
neurofeedback training in children with attention deficit/hyperactivity disorder: A cognitive
and behavioral outcome study. Clin. EEG Neurosci. 50, 242–255.
doi:10.1177/1550059418813034.
Wang, Z. (2017). Neurofeedback training intervention for enhancing working memory function in
attention deficit and hyperactivity disorder (ADHD) Chinese students. Neuroquantology
15, 277–283. doi:10.14704/nq.2017.15.2.1073.
CASE REPORTS
doi:10.1177/1039856217715988.
Riaño Garzón, M. E. (2018). Neurofeedback training to increase of cognitive skills in patient with
traumatic brain injury (TBI). JNSK 8. doi:10.15406/jnsk.2018.08.00270.
Surmeli, T., Eralp, E., Mustafazade, I., Kos, H., Özer, G. E., and Surmeli, O. H. (2016).
Quantitative EEG neurometric analysis-guided neurofeedback treatment in dementia: 20
37

cases. How neurometric analysis is important for the treatment of dementia and as a
biomarker? Clin. EEG Neurosci. 47, 118–133. doi:10.1177/1550059415590750.
REVIEWS
Angelakis, E., Stathopoulou, S., Frymiare, J. L., Green, D. L., Lubar, J. F., and Kounios, J.
(2007). EEG neurofeedback: A brief overview and an example of peak alpha frequency
training for cognitive enhancement in the elderly. Clin. Neuropsychol. 21, 110–129.
doi:10.1080/13854040600744839.
Foster, P. P., Baldwin, C. L., Thompson, J. C., Espeseth, T., Jiang, X., and Greenwood, P. M.
(2019). Editorial: Cognitive and brain aging: Interventions to promote well-being in old
age. Front. Aging Neurosci. 11, 268. doi:10.3389/fnagi.2019.00268.
Jiang, Y., Abiri, R., and Zhao, X. (2017). Tuning up the old brain with new tricks: Attention
training via neurofeedback. Front. Aging Neurosci. 9, 52. doi:10.3389/fnagi.2017.00052.
Kouzak Campos da Paz, V., and Tomaz, C. (2020). “Neurofeedback training on aging:
Prospects on maintaining cognitive reserve,” in Mental Disorders (IntechOpen).
doi:10.5772/intechopen.90847.
Vigil, J., and Tataryn, L. (2017). Neurotherapies and Alzheimer’s: A protocol-oriented review.
NeuroRegulation 4, 79–94. doi:10.15540/nr.4.2.79.
Depression
STUDIES
Baehr, E., Rosenfeld, J. P., and Baehr, R. (2001). Clinical use of an alpha asymmetry
neurofeedback protocol in the treatment of mood disorders. J. Neurother. 4, 11–18.
doi:10.1300/J184v04n04_03.
Choi, S. W., Chi, S. E., Chung, S. Y., Kim, J. W., Ahn, C. Y., and Kim, H. T. (2011). Is alpha
wave neurofeedback effective with randomized clinical trials in depression? A pilot study.
Neuropsychobiology 63, 43–51. doi:10.1159/000322290.
38

Liu, H. (2017). Neurofeedback training intervention for persons with major depression disorder:
Reducing depressive symptoms. Neuroquantology 15, 179–184.
doi:10.14704/nq.2017.15.3.1091.
Manchester, C. F., Allen, T., and Tachiki, K. H. (1998). Treatment of dissociative identity
disorder with neurotherapy and group self-exploration. J. Neurother. 2, 40–53.
doi:10.1300/J184v02n04_03.
Peeters, F., Oehlen, M., Ronner, J., van Os, J., and Lousberg, R. (2014). Neurofeedback as a
treatment for major depressive disorder--a pilot study. PLoS ONE 9, e91837.
doi:10.1371/journal.pone.0091837.
Raymond, J., Varney, C., Parkinson, L. A., and Gruzelier, J. H. (2005). The effects of
alpha/theta neurofeedback on personality and mood. Brain Res. Cogn. Brain Res. 23,
287–292. doi:10.1016/j.cogbrainres.2004.10.023.
Psychol. 51, 685–693.
doi:10.1002/1097-4679(199509)51:5<685::AID-JCLP2270510514>3.0.CO;2-K.
Wang, S.-Y., Lin, I.-M., Peper, E., Chen, Y.-T., Tang, T.-C., Yeh, Y.-C., Tsai, Y.-C., and Chu,
C.-C. (2016). The efficacy of neurofeedback among patients with major depressive
disorder: Preliminary study. NR 3, 127–134. doi:10.15540/nr.3.3.127.
White, E. K., Groeneveld, K. M., Tittle, R. K., Bolhuis, N. A., Martin, R. E., Royer, T. G., and
Fotuhi, M. (2017). Combined neurofeedback and heart rate variability training for
individuals with symptoms of anxiety and depression: A retrospective study. NR 4,
37–55. doi:10.15540/nr.4.1.37.
CASE REPORTS
doi:10.1177/1039856217715988.
Unterrainer, H. F., Chen, M. J. L., and Gruzelier, J. H. (2014). EEG-neurofeedback and
psychodynamic psychotherapy in a case of adolescent anhedonia with substance
39

misuse: mood/theta relations. Int. J. Psychophysiol. 93, 84–95.
doi:10.1016/j.ijpsycho.2013.03.011.
REVIEWS
Hammond, D. C. (2005a). Neurofeedback with anxiety and affective disorders. Child Adolesc.
Psychiatr. Clin. N. Am. 14, 105–23, vii. doi:10.1016/j.chc.2004.07.008.
Hammond, D. C. (2005b). Neurofeedback treatment of depression and anxiety. J. Adult Dev.
12, 131–137. doi:10.1007/s10804-005-7029-5.
doi:10.1016/j.neucli.2015.10.077.
Rosenfeld, J. P. (2000). An EEG biofeedback protocol for affective disorders. Clin
Electroencephalogr 31, 7–12. doi:10.1177/155005940003100106.
Walker, J., Lawson, R., and Kozlowski, G. (2007). “Current status of QEEG and neurofeedback
in the treatment of clinical depression,” in Handbook of Neurofeedback: Dynamics and
Clinical Applications, ed. J. Evans (New York: CRC Press), 341–352.
doi:10.1201/b14658-19.
Eating Disorders
STUDIES
Fattahi, S., Naderi, F., Asgari, P., and Ahadi, H. (2017). Neuro-feedback training for overweight
women: Improvement of food craving and mental health. Neuroquantology 15.
doi:10.14704/nq.2017.15.2.1067.
40

Imperatori, C., Valenti, E. M., Della Marca, G., Amoroso, N., Massullo, C., Carbone, G. A.,
Maestoso, G., Quintiliani, M. I., Contardi, A., and Farina, B. (2017). Coping food craving
with neurofeedback. Evaluation of the usefulness of alpha/theta training in a non-clinical
sample. Int. J. Psychophysiol. 112, 89–97. doi:10.1016/j.ijpsycho.2016.11.010.
Lackner, N., Unterrainer, H.-F., Skliris, D., Shaheen, S., Dunitz-Scheer, M., Wood, G., Scheer,
P. J. Z., Wallner-Liebmann, S. J., and Neuper, C. (2016). EEG neurofeedback effects in
the treatment of adolescent anorexia nervosa. Eat. Disord. 24, 354–374.
doi:10.1080/10640266.2016.1160705.
Schmidt, J., and Martin, A. (2016). Neurofeedback against binge eating: A randomized
controlled trial in a female subclinical threshold sample. Eur. Eat. Disord. Rev. 24,
406–416. doi:10.1002/erv.2453.
Schmidt, J., and Martin, A. (2015). Neurofeedback reduces overeating episodes in female
restrained eaters: A randomized controlled pilot-study. Appl. Psychophysiol. Biofeedback
40, 283–295. doi:10.1007/s10484-015-9297-6.
REVIEWS
Imperatori, C., Mancini, M., Della Marca, G., Valenti, E. M., and Farina, B. (2018).
Feedback-based treatments for eating disorders and related symptoms: A systematic
review of the literature. Nutrients 10. doi:10.3390/nu10111806.
McGinnis, A. (2018). “Neurofeedback and the eating disordered brain,” in Trauma-Informed
Approaches to Eating Disorders, eds. A. Seubert and P. Virdi (New York, NY: Springer
Publishing Company). doi:10.1891/9780826172655.0011.
Schmidt, J., Kärgel, C., and Opwis, M. (2017). Neurofeedback in substance use and overeating:
Current applications and future directions. Curr. Addict. Rep. 4, 116–131.
doi:10.1007/s40429-017-0137-z.
41

Epilepsy
STUDIES
Ayers, M. (1995). Long-term follow-up of EEG neurofeedback with absence seizures.
Biofeedback and Self-Regulation 20, 309.
Ayers, M. E. (1988). Long-term clinical treatment follow-up of EEG neurofeedback for epilepsy.
Epilepsy Support Program Newsletter 3, 8–9.
Finley, W. W., Smith, H. A., and Etherton, M. D. (1975). Reduction of seizures and normalization
of the EEG in a severe epileptic following sensorimotor biofeedback training: preliminary
study. Biol. Psychol. 2, 189–203. doi:10.1016/0301-0511(75)90019-8.
Fischer-Williams, M., and Clifford, B. C. (1988). Biofeedback treatment of patients with seizures:
A pilot study of EEG feedback. Electroencephalogr Clin Neurophysiol 70, 18.
Frey, L. (2016). Impact of sensorimotor rhythm neurofeedback on quality of life in patients with
medically-refractory seizures. NR 3, 3–6. doi:10.15540/nr.3.1.3.
Hansen, L. M., Trudeau, D. L., and Grace, D. L. (1996). Neurotherapy and drug therapy in
combination for adult ADHD, personality disorder, and seizure disorder. J. Neurother. 2,
6–14. doi:10.1300/J184v02n01_02.
Kaplan, B. J. (1975). Biofeedback in epileptics: Equivocal relationship of reinforced EEG
frequency to seizure reduction. Epilepsia 16, 477–485.
doi:10.1111/j.1528-1157.1975.tb06076.x.
Lubar, J. F., and Bahler, W. W. (1976). Behavioral management of epileptic seizures following
EEG biofeedback training of the sensorimotor rhythm. Biofeedback Self Regul. 1,
77–104. doi:10.1007/bf00998692.
Monderer, R. S., Harrison, D. M., and Haut, S. R. (2002). Neurofeedback and epilepsy. Epilepsy
Behav. 3, 214–218. doi:10.1016/s1525-5050(02)00001-x.
Morales-Quezada, L., Martinez, D., El-Hagrassy, M. M., Kaptchuk, T. J., Sterman, M. B., and
Yeh, G. Y. (2019). Neurofeedback impacts cognition and quality of life in pediatric focal
epilepsy: An exploratory randomized double-blinded sham-controlled trial. Epilepsy
Behav. 101, 106570. doi:10.1016/j.yebeh.2019.106570.
Seifert, A. R., and Lubar, J. F. (1975). Reduction of epileptic seizures through EEG biofeedback
training. Biol. Psychol. 3, 157–184. doi:10.1016/0301-0511(75)90033-2.
42

Sterman, M. B. (1977). “Effects of sensorimotor EEG feedback training on sleep and clinical
manifestations of epilepsy,” in Biofeedback and Behavior, eds. J. Beatty and H. Legewie
(Boston, MA: Springer US), 167–200. doi:10.1007/978-1-4684-2526-0_12.
Sterman, M. B. (1973a). Neurophysiologic and clinical studies of sensorimotor EEG biofeedback
training: Some effects on epilepsy. Semin. Psychiatry 5, 507–525.
Sterman, M. B. (1973b). “Neurophysiological and clinical studies of sensorimotor EEG
biofeedback training: Some effects on epilepsy,” in Biofeedback: Behavioral Medicine,
ed. L. Birk (New York: Grune & Stratton), 147–165.
Sterman, M. B., and Lantz, D. (2001). Changes in lateralized memory performance in subjects
with epilepsy following neurofeedback training. J. Neurother. 5, 63–72.
doi:10.1300/J184v05n01_06.
Swingle, P. G. (1998). Neurofeedback treatment of pseudoseizure disorder. Biol. Psychiatry 44,
1196–1199. doi:10.1016/s0006-3223(97)00541-6.
Tozzo, C. A., Elfner, L. F., and May, J. G. (1988). EEG biofeedback and relaxation training in
the control of epileptic seizures. Int. J. Psychophysiol. 6, 185–194.
doi:10.1016/0167-8760(88)90004-9.
Zhao, L., Liang, Z., Hu, G., and Wu, W. (2005). Nonlinear analysis in treatment of intractable
epilepsy with EEG biofeedback. Conf. Proc. IEEE Eng. Med. Biol. Soc. 5, 4568–4571.
doi:10.1109/IEMBS.2005.1615486.
CASE REPORTS
Legarda, S. B., McMahon, D., Othmer, S., and Othmer, S. (2011). Clinical neurofeedback: Case
studies, proposed mechanism, and implications for pediatric neurology practice. J. Child
Neurol. 26, 1045–1051. doi:10.1177/0883073811405052.
Tansey, M. A. (1985). The response of a case of petit mal epilepsy to EEG sensorimotor rhythm
biofeedback training. Int. J. Psychophysiol. 3, 81–84.
doi:10.1016/0167-8760(85)90029-7.
43

REVIEWS
Egner, T., and Sterman, M. B. (2006). Neurofeedback treatment of epilepsy: From basic
rationale to practical application. Expert Rev. Neurother. 6, 247–257.
doi:10.1586/14737175.6.2.247.
Malkowicz, D., and Martinez, D. (2009). Role of quantitative electroencephalography,
neurotherapy, and neuroplasticity in recovery from neurological and psychiatric
disorders. J. Neurother. 13, 176–188. doi:10.1080/10874200903127049.
doi:10.1016/j.neucli.2015.10.077.
Nigro, S. E. (2019). The efficacy of neurofeedback for pediatric epilepsy. Appl. Psychophysiol.
Biofeedback 44, 285–290. doi:10.1007/s10484-019-09446-y.
Sterman, M. B. (1997). The challenge of EEG biofeedback in the treatment of epilepsy: A view
from the trenches. Biofeedback 25, 6–7.
Sterman, M. B., and Egner, T. (2006). Foundation and practice of neurofeedback for the
treatment of epilepsy. Appl. Psychophysiol. Biofeedback 31, 21–35.
doi:10.1007/s10484-006-9002-x.
Tan, G., Thornby, J., Hammond, D. C., Strehl, U., Canady, B., Arnemann, K., and Kaiser, D. A.
(2009). Meta-analysis of EEG biofeedback in treating epilepsy. Clin. EEG Neurosci. 40,
173–179. doi:10.1177/155005940904000310.
Walker, J. E., and Kozlowski, G. P. (2005). Neurofeedback treatment of epilepsy. Child Adolesc.
Psychiatr. Clin. N. Am. 14, 163–76, viii. doi:10.1016/j.chc.2004.07.009.
44

Neurofeedback Research Overview (V2)

Neurofeedback Research Overview (V2)

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Ähnlich wie Neurofeedback Research Overview (V2)

Ähnlich wie Neurofeedback Research Overview (V2) (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Neurofeedback Research Overview (V2)